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1. SUMMARY 
PICH (Plk1-interacting checkpoint helicase), a DNA-dependent ATPase, was identified as a 
binding partner and substrate of Plk1. During mitosis, PICH localizes to the centromere/KTs of 
condensed mitotic chromosomes and to ultra-fine DNA bridges (UFBs) during anaphase. Upon 
depletion or chemical inhibition of Plk1, PICH localizes to the chromosome arms, suggesting 
that the kinase activity of Plk1 regulates the dynamic localization of PICH. In addition, PICH 
(bound to Plk1) has been proposed to function in prometaphase chromosome arm architecture 
and cohesion. Here, two questions were asked: how is the dynamic localization of PICH 
regulated and what is the mitotic function of PICH? 
In the first part of this thesis, we identify the ATPase activity of PICH as being essential for its 
correct subcellular localization and show that ATPase-dead mutants of PICH localize to the 
chromosome arms. Rescue experiments with a mutant of PICH that is unable to interact with 
Plk1 imply that the kinase activity of Plk1 is only indirectly required to delocalize PICH from the 
chromosome arms. This suggests that an unknown Plk1 substrate regulates the localization of 
PICH. PICH-immunoprecipitation and mass spectrometry identified the uncharacterized protein 
BEND3 as a binding partner. BEND3 localizes to mitotic chromosomes and its depletion results 
in the loss of PICH and Plk1 from the centromere/KTs. BEND3 depleted cells are unable to align 
their chromosomes at the metaphase plate and undergo apoptosis within a short time, suggesting 
that BEND3 regulates not only the localization of PICH and Plk1 but has additional functions. 
In the second part of this thesis, we demonstrate that PICH does not function in the spindle 
assembly checkpoint. Instead, we show that neutralization or depletion of PICH results in 
chromatin bridges during anaphase. We identify the ATPase activity of PICH as indispensable to 
prevent the formation of these bridges and show that they most likely arise from non-centromeric 
chromatin. PICH was previously shown to interact with the BTR complex (composed of BLM, 
TOP3A and RMI1) that has been linked to the faithful separation of chromosomes during mitosis. 
It is of great interest, therefore, that we discovered an association of PICH with Rif1, which has 
recently been shown to provide a DNA-binding interface for the BTR complex. In contrast to the 
colocalization of PICH and the BTR complex to non-centromeric UFBs, Rif1 localizes to 
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centromeric UFBs in a PICH-dependent manner. Thus, we speculate that PICH, Rif1 and the 
BTR complex act together to prevent chromatin bridges during mitosis. 
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2. INTRODUCTION 
2.1 The cell cycle 
The reproduction of cells is fundamental to the development of all life. In single-celled 
organisms, one cell division leads to two new organisms. In the development of multi-cellular 
organisms, countless cell divisions convert a single cell into the diverse communities of cells that 
make up tissues and organs. Apart from that, cell division is important to replace dead cells in 
the adult organism. Cell division is divided into a series of distinct, highly regulated and 
coordinated processes, called the cell cycle. The cell cycle ensures that a cell duplicates its 
contents before dividing into two daughter cells. 
Division and duplication of cellular components has to be achieved with great precision and 
reliability over many generations. This is in particular true for the genetic information stored in 
the DNA of the chromosomes which duplicate once and only once per cell cycle. In eukaryotes, 
DNA is replicated during S (synthesis) phase into identical sister chromatids, which then must 
equally segregate into the daughter cells during M (mitotic) phase (Figure 1). 
 
Figure 1: The eukaryotic cell cycle. Interphase consists of G1, S and G2 phase. M phase is composed of nuclear 
division (mitosis) and cell division (cytokinesis). Illustration adapted from “Physiology or Medicine for 2001 - Press 
Release", Nobelprize.org. 
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The accuracy of cell reproduction depends on regulatory feedback mechanisms to make sure that 
cell cycle events occur in the correct order and errors are not propagated. In line with this, 
transition into M phase depends on the completion of DNA replication, ensuring that sister 
chromatid separation occurs after S phase. Mitosis and S phase are separated be gap-phases (G1 
and G2) that provide additional time to prepare the following cell cycle stage. G1 is particular 
important as cells determine to either continue cell division or exit from the cell cycle. In the 
presence of negative growth conditions or inhibitory signals, cells arrest in G1 or enter a 
nondividing state (G0) until positive growth conditions are present again. 
 
2.2 The events of mitosis 
In 1882, Walther Flemming became the first cytologist to describe the segregation of 
chromosomes during cell division, a process he called mitosis (Flemming, 1882). More than 100 
years later, in 2001, Leland H. Hartwell, Tim Hunt and Sir Paul M. Nurse received the Nobel 
Prize in Physiology and Medicine for the discovery of key components of the molecular 
mechanisms behind Flemming’s initial observations. 
Mitosis or nuclear division is part of the cell cycle that encompasses the time in which sister 
chromatids are segregated equally to the two daughter cells. This time can be divided into five 
morphological distinct phases (Figure 2). 
 Prophase: The first mitotic phase in which the interphase chromatin condenses. The 
centrosomes (cellular organelle that serves as the main microtubule organizing center (MTOC)), 
which have been duplicated during S phase, separate and move to opposite poles. There, by 
nucleating microtubules (MTs) the initiation of spindle assembly occurs. 
 Prometaphase: The second mitotic phase, characterized by nuclear envelope breakdown 
(NEBD). A specialized structure at both sister chromatids, called kinetochore (KT), assembles 
on the centromeric region. During a highly dynamic and stochastic process KTs are captured by 
MTs and sister chromatids congress to the central region (metaphase or equatorial plate). 
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 Metaphase: The third mitotic phase, in which sister chromatids are bipolar attached and 
aligned at the metaphase plate. Cells await the signal to separate. MTs form the typical bipolar 
spindle with their minus-ends proximal to the poles and their plus ends attached to the KTs. 
 Anaphase: The fourth and most “dramatic” phase of mitosis. Once all chromosomes are 
aligned, sister chromatid cohesin is lost and sister chromatids are pulled to opposite poles of the 
spindle (anaphase A). The spindle elongates and the poles move further apart from each other 
(anaphase B). 
 Telophase: The fifth and final phase of mitosis in which chromosomes and nuclear 
components are repacked into the daughter nuclei. The spindle disassembles and the nuclear 
envelope reforms around decondensing chromatids. 
At the end of mitosis, the genetic material has been separated and cell division (cytokinesis) 
occurs. The central spindle compresses to form the midbody and contraction of an actin-myosin 
II-based ring-like structure leads to furrow ingression. Cytokinesis is terminated by abscission, 
resulting in two new genetically identical daughter nuclei. 
 
Figure 2: The events of mitosis. The five phases of mitosis: Prophase, Prometaphase, Metaphase, Anaphase and 
Telophase are characterized by distinct morphological characteristics. Illustration adapted from (Morgan, 2007). 
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2.3 Mitotic kinases 
Post-translational modification of proteins is a key regulatory mechanism to control different 
stages of mitotic progression. Phosphorylation of proteins, mediated by protein kinases, is an 
optimal reversible modification to control mitotic processes such as KT-MT capturing. The two 
mitotic kinases cyclin-dependent kinase 1 (Cdk1) and polo-like kinase 1 (Plk1) will be 
introduced in the following sections. 
 
2.3.1 The family, activation and function of Cdk1 in mitosis 
A hallmark of the cell cycle is the unique and irreversible sequence of events which is controlled 
by a series of biochemical switches. Important components of the cell cycle are cyclin-dependent 
kinases (Cdks) that transiently associate with regulatory subunits called cyclins. Cdks are 
constantly expressed throughout the cell cycle and their enzymatic activity oscillates depending 
on the level of cyclins, phosphorylation and the binding to Cdk inhibitor proteins (CKIs). Cyclins 
are divided into 4 classes, based on their time of expression and function (Table 1). 
Table 1: Cyclin classes in cell cycle. Cyclins are the main determinants of Cdk activity and are classified in four 
groups depending on their time of expression and function. Table adapted from (Morgan, 2007). 
Species 
Cyclin class (with Cdk partner) 
G1 G1/S S M 
S. cerevisiae Cln3 (Cdk1) 
Cln1,2 
(Cdk1) 
Clb5,6 
(Cdk1) 
Clb1,2,3,4 
(Cdk1) 
S. pombe Puc1? (Cdk1) 
Puc1, Cig1? 
(Cdk1) 
Cig2, Cig1? 
(Cdk1) 
Cdc13 
(Cdk1) 
D. melanogaster cyclin D (Cdk4) 
cyclin E 
(Cdk2) 
cyclin E,A 
(Cdk2,1) 
cyclin A,B,B3 
(Cdk1) 
X. laevis  cyclin E (Cdk2) 
cyclin E,A 
(Cdk2,1) 
cyclin A,B 
(Cdk1) 
H. sapiens cyclin D1,2,3 (Cdk4,6) 
cyclin E 
(Cdk2) 
cyclin A 
(Cdk2,1) 
cyclin B 
(Cdk1) 
 
At the onset of mitosis, M phase cyclins associate with and stimulate the activity of Cdk1. In 
addition to M phase cyclins, genetic studies in yeast have identified a network of genes that 
control mitotic entry. The key protein identified was the Saccharomyces cerevisiae Cdc28p and 
the Schizosaccharomyces pombe Cdc2p (renamed Cdk1) protein kinase activated by Cdc25p and 
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inhibited by the Wee1p protein kinase (Hartwell and Smith, 1985; Nurse, 1990; Nurse and 
Thuriaux, 1980; Russell and Nurse, 1986; Russell and Nurse, 1987). In the meantime, several 
studies have elucidated the regulation of Cdk1 activity and its functions during mitosis (Figure 3) 
(Doree and Hunt, 2002; Ferrari, 2006). Before mitosis, Cdk1 is kept inactive by phosphorylation 
of its ATP-binding site at threonine 14 and tyrosine 15 by the protein kinases Wee1 and Myt1 
(Nigg, 2001). At the G2/M transition, the dual-specific phosphatase Cdc25C dephosphorylates 
these two residues and thereby stimulates the activity of Cdk1 (Izumi and Maller, 1993; Krek 
and Nigg, 1991). In addition, multiple feedback loops enhance the activity of Cdk1 at the onset 
of mitosis. Cdk1 phosphorylates and thus stimulates its own activator Cdc25C (Hoffmann et al., 
1993) and phosphorylates its inhibitor Wee1 which leads to its beta-TrCP mediated proteasome-
dependent degradation (Watanabe et al., 2005; Watanabe et al., 2004). Wee1 and Myt1 are 
components of a network which detects the completion of DNA synthesis and repair (Ferrari, 
2006). Therefore, the phosphatase activity of Cdc25C exceeds the kinase activity of Wee1 at the 
onset of mitosis (Nigg, 2001). In addition to Cdc25C and Wee1, Cdk1 may stimulate the activity 
of Plk1 which phosphorylates Cdc25C and thereby further enhances the activity of Cdk1 (Barr et 
al., 2004; Kumagai and Dunphy, 1996; Strausfeld et al., 1994). Furthermore, activity of Cdk1 
also requires phosphorylation of a threonine close to the active site catalyzed by a Cdk-activating 
kinase (CAK) (Obaya and Sedivy, 2002). 
 
Figure 3: Cdk1 activation and positive feedback loops at G2/M transition. Before G2/M transition, Cdk1-cyclin 
B is kept inactive by Wee1 and Myt1 mediated phosphorylation. When the activity of Cdc25 exceeds the activity of 
Wee1 and Myt1, Cdk1-cyclin B gets dephosphorylated and activated. Cdk1 induced phosphorylation of Cdc25 and 
Wee1/Myt1 triggers a positive feedback loop which further enhances the activity of Cdk1-cyclin B. Cdk1 may also 
contributes to Plk1 activation, which influences the activity of Cdc25 and Wee1/Myt1. Illustration adapted from 
(Barr et al., 2004). 
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Once Cdk1 is active, it phosphorylates various substrates and fulfills different functions during 
mitosis. For instance, Cdk1 drives chromosome condensation by phosphorylation of condensins 
(Kimura et al., 1998) and nuclear envelope breakdown by phosphorylation of lamins (Peter et al., 
1991). Furthermore, Cdk1 contributes to centrosome separation and assembly of the mitotic 
spindle by phosphorylation of microtubule-associated proteins and the kinesin-related motor 
protein Eg5 (Blangy et al., 1995). In addition, Cdk1 is involved in the regulation of the anaphase-
promoting complex/cyclosome (APC/C), a multisubunit E3 ubiquitin ligase (Sudakin et al., 1995; 
Zachariae et al., 1998). The APC/C catalyzes the covalent attachment of ubiquitin chains to 
mitotic regulators such as cyclin B or securin which promotes their proteolysis by the 26S 
proteasome (Hagting et al., 2002; Peters, 2002). Upon cyclin B degradation, Cdk1 is inactivated 
and mitotic exit induced. 
 
2.3.2 Polo-like kinase 1 
Kinases like Cdks are the main regulators of the cell cycle, but still they don’t act alone. In recent 
years, several other protein kinases have been identified to control the diverse events of mitosis, 
among them are members of the Polo family (Nigg, 2001). The first member of the Polo-family 
was identified in Drosophila melanogaster (Sunkel and Glover, 1988), followed by the discovery 
of the four human Plk (polo-like kinase) family members (Plk1, 2, 3, and 4) (Barr et al., 2004; 
Glover et al., 1998) (Table 2). 
Table 2: Polo-like protein kinases. Plk members of the most frequent studied model organisms including their 
proposed functions. This table is not meant to be complete. Table adapted from (Barr et al., 2004; Morgan, 2007). 
Species Name (synonymes) proposed functions 
S. cerevisiae Cdc5 Regulation of meiosis, mitosis and mitotic exit 
S. pombe Plo1p Regulatino of mitosis and cytokinesis 
D. melanogaster Polo Regulatino of mitosis and cytokinesis 
C. elegans Plc1, Plc2, Plc3 Required for nuclear-envelope breakdown 
X. laevis 
Plx1 Involved in mitotic entry and mitotic exit 
Plx2 no function determined 
Plx3 no function determined 
Mammals 
Plk1 Regulation of mitosis and cytokinesis 
Plk2 (Snk) DNA-damage response, G1/S function 
Plk3 (Fnk, Prk) DNA-damage response, G2/M function 
Plk4 (Sak) Centrosome duplication, mitotic exit 
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To date, Plk1 is the best studied member of the human Plk family. The amino-terminal half 
contains a catalytic kinase domain and the carboxy-terminal half composes two structurally 
homologous polo-boxes, called Polo-box domain (PBD, Figure 4A) (Elia et al., 2003b; Leung et 
al., 2002). The PBD of Plk1 has diverse functions, for instance, it acts as an autoinhibitory 
domain towards the amino-terminal kinase domain (Mundt et al., 1997). Phosphorylation of 
threonine 210 by Aurora A relieves the autoinhibitory function of the PBD and increases the 
kinase activity of Plk1 before entry into mitosis (Archambault and Glover, 2009; Jang et al., 
2002; Macurek et al., 2008; Seki et al., 2008). In addition, Plk’s substrate targeting and 
subcellular localization is controlled by the PBD (Hanisch et al., 2006; Reynolds and Ohkura, 
2003). These two later functions are mediated by high affinity of the PBD for proteins that have 
been phosphorylated at serine or threonine residues within a specific sequence motif (S-
pS/pTP/X) (Elia et al., 2003a). PBD-binding to phosphorylated docking proteins further relieves 
the autoinhibited state and increases the kinase activity of Plk1, leading to the phosphorylation of 
the docking protein and/or other downstream substrates of Plk1 (Baumann et al., 2007; Elia et 
al., 2003a; Elia et al., 2003b; Lowery et al., 2005). The PBD docking site is generated by a 
serine/threonine kinase (priming-kinase) like Cdk1, MAP kinase or Calmodulin-dependent 
kinase II (CaMKII) (Elia et al., 2003a; Elia et al., 2003b; Fabbro et al., 2005; Rauh et al., 2005). 
However, during anaphase Plk1 can self-prime its docking sites on proteins involved in 
cytokinesis (Neef et al., 2007; Neef et al., 2003). In addition, the PBD of Plk1 recruits Plk1 to 
several mitotic structures, including the centrosomes, spindle poles, the KTs, the central spindle 
and to the midbody (Figure 4B). 
Like its dynamic localization, Plk1 has various functions throughout mitosis (Figure 4C). As 
mentioned above, during G2/M transition, Plk1 has been implicated in the activation of Cdk1-
cyclin B1 (Toyoshima-Morimoto et al., 2002; Toyoshima-Morimoto et al., 2001; Watanabe et 
al., 2004), centrosome maturation and bipolar spindle formation (Lane and Nigg, 1996; Sumara 
et al., 2004; van Vugt and Medema, 2004). During early mitosis, Plk1 recruits components of the 
spindle assembly checkpoint to the kinetochore (Ahonen et al., 2005; Kang et al., 2006; Wong 
and Fang, 2006), and has been shown to phosphorylate INCENP, Bub1, BubR1 and the DNA-
dependent ATPase PICH (Baumann et al., 2007; Elowe et al., 2007; Goto et al., 2006; Qi et al., 
2006). At the same time, Plk1 phosphorylates the cohesin subunit SA2 which contributes to the 
removal of sister chromatid arm cohesion (Hauf et al., 2005; Sumara et al., 2002). Interestingly, 
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the separation of sister chromatids seems to be independent of Plk1 function as Plk1 deficient 
cells still separate their chromatids when forced to enter anaphase (Gimenez-Abian et al., 2004). 
Besides its contribution to early mitosis, Plk1 is involved in late mitotic events, for instance 
targeting Mklp2 or PRC1 to the central spindle (Carmena et al., 1998; D'Avino et al., 2007). 
Furthermore, Plk1 activity promotes the recruitment of Ect2 to the central spindle, triggering the 
initiation of cytokinesis and contributing to the specification of the cleavage plane (Brennan et 
al., 2007; Burkard et al., 2007; Petronczki et al., 2007). Together, Plk1 has numerous mitotic 
functions but more await their elucidation. 
 
Figure 4: Structure, localization and functions of Plk1 during mitosis. A) Schematic representation of human 
Plk1, illustrating the open-reading frame in length, indicated by amino-acid number. Depicted are the position of the 
kinase domain, PBD, nuclear localization sequence (NLS) and the destruction-box (D-box). Residues essential for 
ATP binding, kinase activity and phospho-selectivity within the PBD are highlighted. B) Immunofluorescence 
images illustrating the dynamic localization of human Plk1 throughout mitosis. C) Mitotic functions of human Plk1 
below the indicated mitotic stage. Illustration adapted from (Barr et al., 2004; Petronczki et al., 2008; Strebhardt and 
Ullrich, 2006). 
 
2.4 The spindle assembly checkpoint 
In 1991, two parallel screens performed in yeast identified genes, which, when mutated, 
bypassed the ability to induce a mitotic arrest in response to spindle poisons (Hoyt et al., 1991; 
Li and Murray, 1991). Genes identified in these screens include the MAD (mitotic-arrest 
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deficient) and the BUB (budding uninhibited by benimidazole) genes that act in a highly 
sensitive surveillance mechanism called the spindle assembly checkpoint (SAC). The SAC, 
conserved in all eukaryotes, senses the correct bipolar (amphitelic, from both poles) attachment 
of KTs to MTs to ensure that replicated sister chromatids are equally distributed to daughter cells 
(Cleveland et al., 2003; Li and Murray, 1991; Musacchio and Hardwick, 2002; Pinsky and 
Biggins, 2005; Stern and Murray, 2001). Thus, anaphase-onset is delayed until all chromosomes 
are properly attached and aligned at the metaphase plate and cell-biological studies have shown 
that a single unattached kinetochore is sufficient to inhibit the onset of anaphase (Rieder et al., 
1995). During early mitosis, SAC proteins are recruited to unattached kinetochores and create a 
“wait anaphase signal” (Chen et al., 1996; Taylor and McKeon, 1997). How this “wait anaphase 
signal” is generated is currently discussed, but the phosphorylation state of SAC proteins seems 
to contribute to SAC activity (Ahonen et al., 2005; Elowe et al., 2007; Nicklas et al., 1995). 
However, the molecular source of the inhibitory signal remains elusive. 
The SAC should only be silenced once all sister KTs are bipolar attached, to ensure equal 
segregation of chromatids during anaphase (Figure 5). In contrast, monotelic attachments are 
characterized by the attachment of only one sister KT to MTs, a normal condition during 
prometaphase. Furthermore, MTs from only one pole might attach to both sister KTs (syntelic 
attachment) or a single KT is captured by MTs from opposite poles (merotelic attachment). 
Several lines of evidence indicate that the SAC senses tension across sister KTs upon MT 
attachment. Therefore, the SAC is activated by syntelic attachments (low tension) and the KT-
MT attachment is destabilized, but satisfied by high tension between amphitelic-attached sister 
KTs (Nicklas et al., 1995; Nicklas et al., 2001; Rieder et al., 1995; Rieder et al., 1994). Merotelic 
attachments are not sensed by the SAC due to their ability to produce sufficient tension. Still, 
merotelic and syntelic attachments are destabilized by the action of the protein kinase Aurora B, 
member of the chromosomal passenger complex (CPC), probably by regulating the microtubule 
depolymerase MCAK (Andrews et al., 2004; Biggins and Murray, 2001; Ditchfield et al., 2003; 
Giet et al., 2005; Hauf et al., 2003; Tanaka et al., 2002). Uncorrected KT-MT attachments can 
result in lagging chromatids and chromosome missegregation during anaphase which highlights 
the importance of their correction; but to which extent a lack of MT attachment or tension 
contributes to SAC inactivation and where and how tension is sensed remain elusive (Musacchio 
and Hardwick, 2002; Pinsky and Biggins, 2005). 
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Figure 5: KT-MT attachments. Amphitelic attachments (3) of sister KTs promote anaphase onset (7). Syntelic (1) 
or monotelic (2) attachments prevent SAC silencing and anaphase onset. Merotelic (4) attachments are not sensed by 
the SAC. Incorrect KT-MT attachments, if not corrected by Aurora B, can result in lagging chromatids and 
chromosome missegregation during anaphase (5 and 6). Illustration adapted from (Giet et al., 2005). 
 
Genetical and biochemical studies identified various proteins involved in SAC signaling, notably 
Mad1, Mad2, Bub3 and the protein kinases Bub1, BubR1 and Mps1. Mad2 is a major effector of 
the SAC and can adopt two conformational states, the inactive “open” and the active “closed” 
conformation (Mapelli et al., 2007; Musacchio and Salmon, 2007; Yu, 2006). The 
conformational transition of Mad2 is probably catalyzed by a Mad1:Mad2 interaction at the 
kinetochore. The Mad1:Mad2 complex thereby acts as a template to generate the “closed” 
conformation of Mad2 by a mechanism know as conformational dimerization. “Closed” Mad2 is 
a potent binding partner of Cdc20, a KT-bound cofactor of the E3 ubiquitin ligase APC/C (Peters, 
2006; Yu, 2007). In addition, a mitotic checkpoint complex (MCC), composed of Bub3, BubR1, 
“closed” Mad2 and Cdc20, has been identified to efficiently inhibit the APC/C (Hardwick et al., 
2000; Morrow et al., 2005; Sudakin et al., 2001). Still, how the MCC assembles and inhibits the 
APC/C is currently unclear (Herzog et al., 2009; Nilsson et al., 2008; Sczaniecka and Hardwick, 
2008). Furthermore, the SAC components Mad1, Bub1, Mps1 and Aurora B are required to 
enhance the SAC signal and rate of MCC formation (Abrieu et al., 2001; Morrow et al., 2005); 
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but again, how these proteins act together to inhibit the APC/C remains elusive. However, as 
soon as sister chromatids are bipolar attached and aligned at the metaphase plate, the SAC needs 
to be silenced in order to induce anaphase. Among others, two prominent mechanisms contribute 
to SAC silencing. First, p31/comet, a protein that binds with high affinity to “closed” Mad2 and 
thereby inhibits the conformational dimerization of Mad2 (Musacchio and Salmon, 2007). The 
second mechanism centers on the dynein dependent “stripping” of Mad1, Mad2 and other 
checkpoint components from the KT to the spindle poles along MTs (Howell et al., 2001; Maiato 
et al., 2004; Wojcik et al., 2001). Once the SAC is satisfied and turned “off”, activated APC/C 
ubiquitinylates and thus promotes the proteolysis of two key substrates, cyclin B1 and securin 
(Figure 6) (Bharadwaj and Yu, 2004; Pines, 2006). Securin is an inhibitory binding partner of 
separase, a cystein protease that cleaves sister chromatid cohesin. Therefore, anaphase onset is 
initiated by the activation of separase and inactivation of Cdk1. 
 
Figure 6: Simplified model for SAC signaling in mitosis. Immunofluorescence images: DNA and MTs are 
marked in purple and green, respectively. To enter mitosis, cells require the activity of Cdk1-cyclin B. Prior to 
anaphase, the activity of the protease separase is restricted by binding to securin. Unattached KTs (red hemi-circles) 
contribute to MCC formation, which blocks the ability of Cdc20 to activate the APC/C. Bipolar attachment of sister 
KTs (shown as white dots) promotes SAC silence and release of Cdc20 that activates the APC/C. The APC/C 
mediates the ubiquinylation and thereby the degradation of cyclin B and securin. Once activated, separase cleaves 
the cohesin ring complex that holds sister chromatids together, promoting sister chromatid separation. Degradation 
of cyclin B inactivates Cdk1 and initiates mitotic exit. Illustration adapted from (Yanagida, 2009). 
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2.5 Snf2 type helicases 
DNA and RNA play central roles in diverse cellular processes such as transcription, 
recombination, genome replication, repair, expression and epigenetics. Therefore, DNA and 
RNA structure, compaction and accessibility are controlled by many proteins, including enzymes 
to spatially and temporally modulate DNA and RNA depending on the requirements of the cell. 
In 1976, the enzymatic unwinding of DNA was described in bacteria (Escherichia coli) (Abdel-
Monem et al., 1976; Abdel-Monem and Hoffmann-Berling, 1976). Since then, proteins that 
enzymatically unwind DNA or RNA (helicases) were identified in all organisms. In 1988, a large 
group of proteins was identified, members of which share a series of short ordered motifs, named 
helicase motifs (Gorbalenya and Koonin, 1988; Gorbalenya et al., 1988a; Gorbalenya et al., 
1988b). The motifs are sequentially labeled I, Ia, II, III, IV, V and VI and comprise the classical 
Walker A (phosphate-binding loop) and Walker B (Mg2+-binding aspartic acid) motifs 
(Gorbalenya and Koonin, 1993). This group of proteins is subdivided, based on their similarity, 
into so-called superfamilies (SF) 1, 2 and 3 (SF1, SF2 and SF3, respectively) (Subramanya et al., 
1996). Structural characterization revealed that SF1 and SF2 are related to each other by a 
common core of two recA-like domains (Subramanya et al., 1996), whereas SF3 type helicases 
share only three conserved motifs. The Snf2 class of helicases is a subclass of the SF2 
superfamily, which members share a helicase-like region similar to the Saccharomyces 
cerevisiae protein Snf2p. Based on sequence alignments, the Snf2 class family is further 
subdivided into subfamilies like Snf2-like, Iswi-like, Chd1-like, SSO1653-like and Rad54-like 
(Figure 7) (Eisen et al., 1995; Flaus et al., 2006). 
 
Figure 7: Snf2 family-tree. Schematic diagram illustrating the hierarchical classification of superfamily, family and 
subfamily. Illustration adapted from (Flaus et al., 2006). 
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Initially identified in screens for genes involved in the yeast phenotypes mating-type switching 
(SWI) and sucrose non-fermenting (SNF) (Carlson and Laurent, 1994; Nasmyth and Shore, 1987; 
Neigeborn and Carlson, 1987; Stern et al., 1984), the Snf2 protein was shown to function as the 
catalytic subunit of the multi-subunit SWI/SNF chromatin remodeling complex (Becker and 
Horz, 2002). SWI/SNF proteins are rare in yeast, but 5-7% of the yeast genes require the activity 
of the SWI/SNF chromatin remodeling complex for their expression, highlighting its importance 
for various pathways (Monahan et al., 2008; Zraly et al., 2006). 
Many Snf2 related proteins have been identified, often as parts of multi-subunit protein 
complexes, for instance the SWI/SNF, RSC, Swr1, Tra1 or the INO80 complex (Cote et al., 1994; 
Liu et al., 2001; Saha et al., 2002; van Attikum and Gasser, 2005). In contrast to classical 
processive helicases, Snf2 related helicases metabolize ATP to regulate processes like replication, 
transcription, recombination, translocation along double stranded DNA (dsDNA), DNA repair, 
chromatin remodeling or to generate superhelical torsion (Becker and Horz, 2002; Beerens et al., 
2005; Durr et al., 2006; Havas et al., 2001; Lia et al., 2006; Saha et al., 2002; Svejstrup, 2003). 
Together, Snf2 family helicases are often part of large multi-subunit protein complexes that 
regulate chromatin structure. Still, it remains elusive how ATP hydrolysis can change the 
structure of DNA in detail and how domains, polypeptides and motifs within Snf2 family 
complexes act together. 
 
2.6 Plk1-interacting checkpoint helicase (PICH) 
The DNA-dependent ATPase PICH (Plk1-interacting checkpoint helicase) was first identified in 
a Plk1-PBD Far Western ligand binding assay as a strong binding partner and substrate of Plk1 
(Baumann et al., 2007). Sequence analysis characterized PICH as a Snf2 family related helicase 
harboring an amino-terminal Snf2-like helicase domain (including Walker A and B motifs for 
ATP metabolization) upstream of an extended HELICc domain (Figure 8). In addition, two TPR 
(tetratricopeptide repeat) motifs known to mediate protein-protein interactions were identified at 
the very amino- and carboxy-terminal end of PICH (Lamb et al., 1995). The HELICc extension 
shares high homology with the human Snf2 family members CSB/ERCC6 and the Rad54 protein. 
Therefore, PICH was suggested to be a member of the Rad54-like helicases or the Snf2 family of 
helicases SF2 subfamilies (Baumann et al., 2007; Eisen et al., 1995; Flaus et al., 2006). Within 
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the PICH sequence, a new motif located carboxy-terminally to the HELICc domain was 
identified and called PICH-family domain (PFD) (Baumann et al., 2007). Sequence alignments, 
using the PFD sequence revealed PICH orthologs in vertebrates, plants, non-vertebrates, 
Dictyostelium and in the single-cell eukaryotic parasite Entamoeba. Interestingly, no PICH 
orthologs were found in yeast or the classical model organisms Drosophila melanogaster or 
Caenorhabditis elegans (Baumann et al., 2007). 
 
Figure 8: Structure of PICH. Illustration depicting the Snf2-like helicase and extended HELICs (C-term) domains. 
The PICH-family domain (PFD), a new motif to identify PICH orthologs. PICH harbors two TPR motifs located at 
the very amino- and carboxy-terminal end. 
 
During early mitosis, PICH localizes to the centromere/KT region of condensed mitotic 
chromosomes (Baumann et al., 2007). Human cells, depleted of PICH by siRNA duplexes failed 
to arrest in mitosis when treated with the MT poisons nocodazole or taxol. Interestingly, these 
cells were unable to recruit the essential SAC component Mad2 to KTs (Baumann et al., 2007), 
suggesting a role for PICH in the SAC. Moreover, PICH was shown to localize to ultra-fine 
DNA bridges (UFBs) composed of centromeric DNA, connecting two sister KTs from anaphase 
onwards (Baumann et al., 2007; Wang et al., 2008). This localization prompted the authors to 
hypothesize a tension-sensor function for PICH as part of the SAC. However, recent work 
showed that the PICH siRNA duplexes used in this early study not only affect PICH, but also 
lower the mRNA and protein level of Mad2 (Hübner et al., 2009), questioning the role of PICH 
in SAC signaling and identifying Mad2 as a sensitive target for off-target effects. 
During anaphase, UFBs increase in length until they become resolved, presumably by the action 
of topoisomerase 2 (Baumann et al., 2007; Wang et al., 2010). Interestingly, components of the 
BTR complex have been shown to colocalize and associate with PICH at anaphase UFBs (Chan 
et al., 2007; Hutchins et al., 2010). The BTR complex, including the RecQ helicase BLM 
(mutated in Bloom syndrome), is essential for the suppression of chromosomal instability (Payne 
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and Hickson, 2009). In addition, the two Fanconi anemia (FA) proteins FANCD2 and FANCI 
have been shown to colocalize with PICH to anaphase UFBs. FANCD2 and FANCI associate 
specifically with fragile site loci and mark abnormal intertwined DNA structures, induced by 
replication stress (Chan et al., 2009a; Naim and Rosselli, 2009a).  
Depletion of Plk1 induces a dramatic change in the localization of PICH from the centromere/KT 
to the chromosome arms (Baumann et al., 2007). Interestingly, the chemical inhibition of Plk1 by 
the small Plk1 inhibitor TAL (ZK-Thiazolidinone) changes the localization of PICH and co-
targeted Plk1 to the chromosome arms (Santamaria et al., 2007). In line with this, PICH and Plk1 
have recently been shown to be involved in prometaphase chromosome arm architecture and 
cohesion (Kurasawa and Yu-Lee, 2010; Leng et al., 2008).  
However, the detailed mechanism of PICH recruitment to the centromere/KT, chromosome arms 
and anaphase UFBs and its function at mitotic chromatin remain elusive. 
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3. AIM OF THIS WORK 
 
First, the DNA-dependent ATPase PICH shows a highly dynamic localization to different 
mitotic structures during mitosis. Early in mitosis, PICH localizes to the centromere/KT of 
condensed mitotic chromosomes and upon depletion or chemical inhibition of Plk1, PICH and 
co-targeted Plk1, gain localization to the chromosome arms. PICH was shown to be a binding 
partner and substrate of the protein kinase Plk1. (Baumann et al., 2007; Santamaria et al., 2007). 
From anaphase on, PICH localizes to ultra-fine DNA bridges, connecting the separating sister 
KTs (Baumann et al., 2007; Wang et al., 2008). The unique localization of PICH to the 
centromere/KT, chromosome arms and ultra-fine DNA bridges prompted us to investigate the 
mechanisms underlying the dynamic localization of PICH. Therefore, we asked which proteins 
or pathways are essential to remove PICH from the chromosome arms and which mechanisms 
protect it at the centromere/KT during early mitosis. 
 
Second, the function of PICH has been studied extensively in the past. On the one hand PICH 
was suggested to be part of the spindle assembly checkpoint pathway, on the other hand PICH as 
well as Plk1 have been proposed to function in prometaphase chromosome arm architecture and 
cohesion (Kurasawa and Yu-Lee, 2010; Leng et al., 2008). However, we have recently shown 
that the siRNA duplexes used in the above studies not only affect PICH, but also reduce the 
mRNA and protein level of the essential SAC component Mad2 (Hübner et al., 2009), thereby 
making functional conclusions during early mitosis difficult. Thus, we reinvestigated the 
function of PICH using methods that do not affect any known proteins directly. Furthermore, we 
set out to identify new interactors of PICH to unravel the mechanisms underlying the function of 
PICH. 
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4. RESULTS 
4.1 Generation of a PICH monoclonal antibody 
To study the dynamic localization and function of PICH during mitosis, a PICH-specific 
monoclonal antibody was generated. A fragment of PICH (79-752aa) was expressed in 
Escherichia coli, purified and used for immunization of mice (Figure 9, A and B). Screening 
followed by subcloning of ELISA-positive clones resulted in 4 different hybridoma cell lines 
(called 142-177-2/9 and 142-26-3/15) that were tested further. Immunofluorescence of HeLaS3 
cells showed that all four antibodies decorate the centromere/KT region of mitotic chromosomes 
(Figure 9, C to F). This staining is sensitive to PICH knockdown by siRNA, demonstrating PICH 
specificity. Furthermore, the antibodies recognize centromeric UFBs induced by Sgo1 depletion 
as has been shown before (Baumann et al., 2007), confirming the reactivity of the antibodies. In 
addition, antibodies 142-26-3 and 142-26-15 detect a single PICH siRNA-sensitive band of 
175kDa in western blot analyzes (Figure 9, E to F), attesting to their specificities. 
 
Figure 9: Characterization of 4 different hybridoma cell lines. A) ExPASy domain prediction of human PICH. B) 
Illustration depicting the truncated specie of PICH used for immunization of mice. C-F) Immunofluorescence and 
western blot analysis of individual hybridoma cell lines. DNA (DAPI) is shown in blue, CREST in green and PICH 
in red. Scale bars represent 10µm. 
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Because PICH localizes to ultra-fine DNA bridges during anaphase that increase in length before 
they become resolved (Baumann et al., 2007), we analyzed the ability of antibody 142-26-3 to 
decorate anaphase UFBs in more detail. Immunofluorescence of HeLaS3 cells showed 
localization of antibody 142-26-3 to anaphase UFBs that resolve during anaphase (Figure 10). 
 
Figure 10: Antibody 142-26-3 decorates anaphase UFBs. Immunofluorescence of HeLaS3 cells stained for DNA 
(DAPI), CREST (blue), alpha-Tubulin (green) and PICH (142-26-3, red). Antibody 142-26-3 specifically decorates 
anaphase UFBs that resolve during anaphase. Scale bar represents 10µm. 
 
To test whether antibody 142-26-3 also recognizes the native form of PICH, we performed 
immunoprecipitation experiments. Lysates of HeLaS3 cells that were synchronized in mitosis 
with nocodazole were used for immunoprecipitation. In contrast to mouse IgGs (negative 
control), antibody 142-26-3 precipitated a protein of approximately 175kDa that was recognized 
by the same antibody in western blotting. Co-precipitation of Plk1 further confirmed the 
reactivity of 142-26-2 with PICH (positive control) (Figure 11). 
 
 
 
Figure 11: Antibody 142-26-3 immunoprecipitates endogenous PICH. Lysates of 
nocodazole synchronized HeLaS3 cells were used for immunoprecipitation. 
Antibody 142-26-3 precipitates a protein of 175kDa bound to Plk1. 
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The characteristics of the four hybridoma cell lines in immunofluorescence, western blot and 
immunoprecipitation are in line with previous results obtained for PICH using a polyclonal 
antibody (Baumann et al., 2007), attesting to their specificities. The properties of the four 
hybridoma cell lines are summarized in Table 3. In this study, antibody 142-26-3 was used, 
unless indicated otherwise. 
 
Table 3: Characterization of 4 different hybridoma cell lines. Hybridoma cell lines were analyzed for their 
isotype and characteristics in IF, WB and IP. (+: positive, -: negative, n.d.: not determined) 
Hybridoma Isotype 
Immuno-
fluorescence 
(IF) 
Endogenous 
protein (WB) 
Immuno-
precipitation 
(IP) 
142-177-2 IgG1 + - n.d. 
142-177-9 IgG1 + - n.d. 
142-26-3 IgG1 + + + 
142-26-15 IgG1 + + n.d. 
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4.2 Mechanisms controlling PICH localization 
 
At the onset of mitosis, PICH localizes to the centromere/KT region of condensed chromosomes. 
Depletion or chemical inhibition of Plk1 causes the relocalization of PICH (and bound Plk1) to 
the chromosome arms, demonstrating that Plk1 regulates the localization of PICH. From early 
anaphase on, PICH associates with UFBs until these become resolved in late anaphase. However, 
the components that determine and regulate the localization of PICH have not been determined 
yet. 
 
4.2.1 PICH at chromosome arms 
4.2.1.1 PICH homodimerizes 
PICH was characterized as a Snf2-like member of the superfamily 2 (SF2) of helicases and 
several proteins of this family have been shown to act as homodimers (Awad et al., 2010; 
Baumann et al., 2007; Boehmer et al., 1993; Gorbalenya and Koonin, 1993). To analyze a 
possible self-association of PICH, we performed co-immunoprecipitation of flag- and myc-
tagged PICH transiently expressed in HEK293T cells. We detected an interaction between flag- 
and myc-tagged PICH. This was independent of the ability to bind Plk1, as the T1063A mutant 
of PICH, that does not bind Plk1, can still homodimerise (Figure 12A). In contrast, no interaction 
between PICH and the chromosomal passenger protein INCENP could be detected, confirming 
the specificity of PICH self-association. 
Within the sequence of PICH, two TPR domains have been predicted (Figure 9A) (Baumann et 
al., 2007). Because TPR domains have been shown to mediate protein-protein interactions 
(Lamb et al., 1995), we analyzed a potential contribution of the TPR domains to the self-
association of PICH by co-immunoprecipitation. Interestingly, PICH oligomerization was not 
abolished when the TPR domains were truncated individually (PICH-N or PICH-C, N- or C-
terminal truncation) or together (PICH-NC) (Figure 12B), indicating that the homodimerisation 
of PICH is not mediated by its TPR domains. 
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Figure 12: PICH oligomerizes independently of its TPR-domains. A) Co-immunoprecipitation of transiently 
transfected PICH in HEK293T cells. PICH oligomerization is independent of Plk1 binding to PICH. No interaction 
of PICH with INCENP confirms specificity of the PICH-PICH interaction. B) Co-immunoprecipitation of 
transiently transfected PICH-TPR mutants in HEK293T cells. Truncation of both TPR domains does not abolish the 
PICH-PICH interaction. PICH-N and PICH-C, either the N- or C-terminal TPR domain is truncated, or both (PICH-
NC). A-B) Asterisk represents IgG-heavy chain. 
 
4.2.1.2 The TPR domains of PICH are required for correct subcellular localization 
During early mitosis PICH specifically localizes to the centromere/KT region of mitotic 
chromosomes. To ask whether the TPR domains of PICH are required for its mitotic localization 
we performed immunofluorescence of HeLaS3 cells, transiently transfected with the TPR-
domain mutants of PICH. Truncation of either the amino- or carboxy-terminal TPR domain had 
no significant effect on the localization of PICH. But when both TPR domains were truncated, 
PICH localized to the chromosome arms in addition to its centromere/KT localization (Figure 
13). 
Thus, the TPR domains are required for the distinct localization of PICH during early mitosis. 
Furthermore, the chromosome arm localization of PICH-NC suggests that PICH may interact in 
a TPR domain-mediated fashion with an unknown protein that regulates the delocalization of 
PICH from chromosome arms. 
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Figure 13: PICH-TPR domains are required for chromosome arm delocalization of PICH. 
Immunofluorescence of HeLaS3 cells transiently transfected with indicated TPR-domain mutants of PICH. 
Truncation of both PICH-TPR domains results in PICH localization to the chromosome arms. DNA (DAPI) shown 
in blue, PICH (gfp) in green and CREST in red. Scale bar represents 10µm. 
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4.2.1.3 The chromosome arm localization of PICH is regulated by its ATPase activity 
In addition to the significance of the TPR domains for PICH localization we hypothesized that 
the ATPase activity of PICH might regulate its localization. To examine this possibility, we first 
applied low temperature to cultured cells to inhibit all enzymatic reactions that occur within 
living cells and subsequently performed immunofluorescence. When HeLaS3 cells were 
subjected to 4°C for 30 minutes, PICH localized to the chromosome arms (Figure 14A). Since 
the mitotic spindle has been shown to depolymerize at low temperatures (Sillje et al., 2006), we 
used the staining for alpha-Tubulin as control for the low temperature treatment. To further show 
that an enzymatic reaction is required for PICH to delocalize from the chromosome arms, we ask 
whether the effect of cold treatment is reversible. In HeLaS3 cells exposed to 4°C for 30 minutes 
and subsequently transferred to 37°C for 5 minutes PICH localized only to the centromere/KT 
region of mitotic chromosomes (Figure 14B), demonstrating the dynamic association of PICH to 
the chromosome arms. 
To rule out a possible effect of MT-KT attachment in regulating the chromosome arm 
localization of PICH, we compared the localization of PICH in cells treated with nocodazole or 
exposed to low temperatures. In nocodazole treated cells, PICH did not localize to chromosome 
arms (Figure 14C), suggesting that the chromosome arm localization of PICH is MT independent. 
PICH has been shown to be phosphorylated by Cdk1 and Plk1 during mitosis (Baumann et al., 
2007). To ask whether cold treatment affects the phosphorylation of PICH we analyzed the gel 
electrophoretic mobility of PICH by western blot. Compared to nocodazole-arrested cells, cold 
treatment did not detectably change the mobility of PICH (Figure 14D). However, Plk1 has been 
shown to regulate the chromosome arm localization of PICH (Baumann et al., 2007; Santamaria 
et al., 2007). Therefore, we cannot rule out at this stage that the chromosome arm localization of 
PICH in low temperatures is an indirect effect of Plk1 inhibition. 
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Figure 14: PICH localizes to the chromosome arms in cold treatment. A-C) Immunofluorescence of HeLaS3 
cells treated as indicated. DNA was stained with DAPI, PICH is shown in red, alpha-Tubulin in green and CREST 
in blue. Scale bar represents 10µm. D) Western blot of HeLaS3 lysates treated as indicated. The gel-electrophoretic 
mobility of PICH is not affected by low temperatures. 
 
Next, we directly wanted to test whether the ATPase activity of PICH is involved in the dynamic 
localization of PICH. To this end, we generated point mutations within the classical Walker A 
and B motifs of PICH to generate an ATPase-dead mutant (PICH-WAB). To show that this 
mutant is indeed ATPase dead, we performed in vitro ATPase assays with transiently 
overexpressed PICH. In contrast to wild-type PICH (PICH-WT), PICH-WAB was unable to 
metabolize ATP (Figure 15A). Interestingly, when we analyzed the localization of PICH-WAB 
in transiently transfected HeLaS3 cells, PICH-WAB and co-targeted Plk1 localized to the 
chromosome arms and to the centromere/KT region of mitotic chromosomes (Figure 15B). Thus, 
the ATPase activity of PICH is required for the chromosome arm delocalization of PICH. 
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Figure 15: ATPase-dead PICH localizes to the chromosome arms. A) ATPase assay using PICH-WT and PICH-
WAB. Walker A and B motifs of PICH are required for its ATPase activity. ATPase activity is shown in arbitrary 
units (A.U.) as a function of time (min.). Standard deviation obtained after 3 independent experiments. B) 
Immunofluorescence of HeLaS3 cells transiently transfected with PICH-WT and PICH-WAB. PICH-WAB localizes 
to the chromosome arms. DNA was stained with DAPI, PICH (gfp) is shown in green, Plk1 in red and CREST in 
blue. Scale bar represents 10µm. 
 
4.2.1.4 Plk1 indirectly regulates the chromosome arm localization of PICH 
In addition to the role of the TPR domains and the ATPase activity of PICH (see sections 4.2.1.2 
- 3) the kinase activity of Plk1 has been shown to be required for the delocalization of PICH 
from the chromosome arms (Baumann et al., 2007; Santamaria et al., 2007). To analyze whether 
Plk1 directly regulates the chromosome arm localization of PICH by phosphorylation, we 
performed rescue experiments. We mutated the Plk1-binding site (threonine 1063) of PICH to 
alanine (PICH-TA), which completely abolished its binding to Plk1 (Figure 16A). HeLaS3 cells 
were transiently transfected with PICH siRNA duplexes and siRNA-refractory plasmids (Figure 
16B), coding for either PICH-WT or PICH-TA. The cells were arrested in mitosis with 
nocodazole and analyzed by immunofluorescence. Surprisingly, the localization of PICH-TA 
was indistinguishable from that of PICH-WT (Figure 16C), demonstrating that phosphorylation 
of PICH by Plk1 does not regulate the chromosome arm delocalization of PICH. However, when 
Plk1 was subsequently inhibited by the small chemical compound TAL, both PICH-WT and 
PICH-TA localized to the chromosome arms (Figure 16C). This shows that the kinase activity of 
Plk1 is essential for the chromosome arm delocalization of PICH during early mitosis, but that 
the direct phosphorylation of PICH by Plk1 is not required. To date, the Plk1 substrate that 
regulates the dynamic association of PICH with chromatin remains elusive. 
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Figure 16: Plk1 indirectly regulates the chromosome arm localization of PICH. A) Immunoprecipitation of 
PICH and Plk1. PICH Plk1 interaction depends on PICH-T1063 and is independent of Plk1 kinase activity. Asterisk 
represents IgG-heavy chain. B) PICH plasmids are refractory to PICH siRNA after introduction of 7 silent point-
mutations. C) Immunofluorescence of HeLaS3 cells transiently transfected with PICH siRNA and siRNA refractory 
plasmids. Plk1 indirectly regulates the chromosome arm delocalization of PICH. DNA stained with DAPI, PICH 
(gfp) shown in green, Plk1 in red and CREST in blue. Scale bar represents 10µm. 
 
4.2.1.5 Plk1 does not regulate the ATPase activity of PICH 
We have shown that ATPase-inactive PICH (and bound Plk1) localizes to the chromosome arms. 
In addition, PICH localizes to the chromosome arms when Plk1 is depleted or chemically 
inhibited. This raises the question of whether Plk1 regulates the ATPase activity of PICH. In 
order to answer this question we performed in vitro ATPase assays. First, we compared the 
ATPase activity of PICH-WT and PICH-TA that were overexpressed in HEK293T cells arrested 
in nocodazole. No detectable difference in ATPase activity between PICH-WT and PICH-TA 
could be observed (Figure 17A). Second, we analyzed the ATPase activity of PICH-WT in either 
nocodazole- or TAL-arrested cells. Interestingly, TAL treatment did not result in any decrease in 
the ATPase activity of PICH-WT (Figure 17B), demonstrating that Plk1 inhibition does not 
interfere with the ATPase activity of PICH. Finally, we asked whether the ATPase activity of 
PICH changes or is regulated throughout the cell cycle. To our surprise, PICH-WT from 
thymidine-arrested cells was as active as that from nocodazole-arrested cells (Figure 17C), 
suggesting that PICH is constitutively active throughout the cell cycle. Western blot analysis 
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using antibodies against marker proteins confirmed the synchronization at the expected cell cycle 
stage (Figure 17D). 
Taken together, these data show that the ATPase activity of PICH is not regulated by Plk1 and 
does not change during the cell cycle. 
 
Figure 17: Plk1 does not regulate the ATPase activity of PICH. A-C) In vitro ATPase assay using different 
mutants of PICH overexpressed in HEK293T cells. ATPase activity is shown in arbitrary units (A.U.) as a function 
of time (min.). Standard deviation obtained after 3 independent experiments. D) Western blot of HEK293T cells 
treated as indicated, confirming the cell cycle stage. 
 
4.2.1.6 PICH at chromosome arms is independent of sister chromatid arm cohesin 
The above results identify the kinase activity of Plk1 as being indirectly required to remove 
PICH from chromosome arms. However, the direct substrate of Plk1 remains unknown. 
Interestingly, during prophase and prometaphase, when Plk1 acts to remove PICH from the 
chromosome arms, Plk1 phosphorylates the SA2 subunit of chromosome arm cohesin to promote 
sister chromatid arm separation (the prophase pathway) (Hauf et al., 2005; Sumara et al., 2002). 
Thus we asked, whether chromosome arm delocalization of PICH depends on the removal of 
sister chromatid arm cohesin. To this end, we used siRNA duplexes to target the 3’UTR (un-
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translated region) of human SA2 (Figure 18A) and overexpressed a mutant of SA2 that cannot be 
phosphorylated by Plk1 (SA2-12xA; kindly provided by Olaf Stemmann). In 
immunoprecipitation SA2-12xA co-precipitated the cohesin subunits SMC1 and SMC3, 
confirming its in vivo functionality (Figure 18B). Interestingly, when endogenous SA2 was 
replaced by SA2-12xA, PICH localized to the centromere/KT and not to chromosome arms 
(Figure 18C). However, the subsequent inhibition of Plk1 by TAL recruited PICH to 
chromosome arms. Thus, the Plk1 dependent phosphorylation of SA2 does not regulate the 
delocalization of PICH from chromosome arms. 
In addition to the phosphorylation of cohesin subunits by Plk1, a protein called Wapl was shown 
to regulate the dynamic association of cohesin with chromosome arms (Gandhi et al., 2006; 
Kueng et al., 2006). Depletion of Wapl blocks cohesin dissociation from chromosomes during 
the early stages of mitosis and prevents the resolution of sister chromatids (Kueng et al., 2006). 
Therefore, we analyzed the localization of PICH in HeLaS3 cells depleted of Wapl. Western blot 
analysis confirmed the efficiency of previously reported siRNA duplexes targeting Wapl (Figure 
18D) (Kueng et al., 2006). However, immunofluorescence of Wapl-depleted HeLaS3 cells did 
not result in the recruitment of PICH to the chromosome arms (Figure 18E). 
These results show that neither the phosphorylation of SA2 by Plk1 nor the removal of sister 
chromatid arm cohesin during early mitosis regulates the chromosome arm delocalization of 
PICH. Therefore, it is unlikely that sister chromatid arm cohesin is the “Plk1 substrate” that 
regulates the chromosome arm localization of PICH. 
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Figure 18: Dissociation of sister chromatid arm cohesin and chromosome arm delocalization of PICH are 
uncoupled. A) Depletion efficiency of two new SA2 siRNA duplexes analyzed by western blot. B) 
Immunoprecipitation of SA2-12xA transiently transfected into HEK293T cells. SA2-12xA interacts with cohesin 
ring complex components. C) Immunofluorescence of SA2-12xA rescue. SA2 phosphorylation does not regulate the 
chromosome arm localization of PICH. DNA stained with DAPI, myc expression shown in green, PICH in red and 
CREST in blue. Scale bar represents 10µm. D) Depletion efficiency of previously reported Wapl siRNA duplexes 
analyzed by western blot. E) Immunofluorescence of Wapl depleted HeLaS3 cells. Cohesin stabilization does not 
correlate with chromosome arm localization of PICH. DNA (DAPI) shown in blue, PICH in red and CREST in 
green. Scale bar represents 10µm. 
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4.2.2 PICH at the centromere/KT 
4.2.2.1 Centromere/KT localization of PICH is independent of centromere cohesion 
In contrast to the dynamic localization of PICH to the chromosome arms, PICH stably decorates 
the centromere/KT region of mitotic chromosomes. To date, little is known about proteins or 
mechanisms that regulate the localization of PICH at the centromere/KT. 
To characterize this localization of PICH we hypothesized that it might depend on the presence 
of cohesin. In contrast to chromosome arm cohesin, centromere/KT cohesin is protected from 
dissociation by a protein called shugoshin 1 (Sgo1) during early mitosis (Kitajima et al., 2004). 
Sgo1 recruits the protein phosphatase PP2A to the centromere/KT, which has been suggested to 
dephosphorylate cohesin subunits, resulting in stable centromere cohesion (Kitajima et al., 2006). 
Moreover, Sgo2, a paralogue of Schizosaccharomyces pombe Sgo1, has been identified to be 
required for faithful segregation of mitotic chromosomes (Kitajima et al., 2004). Thus, we asked 
whether the centromere/KT localization of PICH depends on centromeric sister chromatid 
cohesion. We transfected HeLaS3 cells with previously reported siRNA duplexes targeting Sgo1 
and Sgo2 and analyzed the localization of PICH. Western blot analysis confirmed the siRNA 
efficiency of the previously reported siRNA duplexes (Figure 19A) (Huang et al., 2007; 
McGuinness et al., 2005). Interestingly, PICH localization at the centromere/KT was unaffected 
when Sgo1, Sgo2 or both were depleted (Figure 19B). 
Thus, the localization of PICH at the centromere/KT is independent of centromeric cohesin and 
cohesion. 
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Figure 19: Centromere/KT PICH is independent of centromeric cohesion. A) Depletion efficiency of Sgo1 and 
Sgo2 siRNA duplexes analyzed by western blot. B) Immunofluorescence of HeLaS3 cells transfected with Sgo1, 
Sgo2 or both siRNA duplexes. PICH localizes to the centromere/KT in the absence of centromeric cohesion. DNA 
was stained with DAPI; PICH is shown in red, Sgo1 in blue and Sgo2 in green. Scale bar represents 10µm. 
 
4.2.2.2 Centromere/KT PICH is protected from Cdk1 and Plk1 
In addition to Plk1, Cdk1 has been shown to phosphorylate PICH, thereby priming PICH for 
Plk1 binding (Baumann et al., 2007). To ask whether Cdk1, like Plk1, contributes to the distinct 
mitotic localization of PICH we treated HeLaS3 cells with either TAL or roscovitine, a chemical 
inhibitor of Cdk1/2 (Rudolph et al., 1996), or both. As mentioned above, TAL treatment 
recruited PICH to the chromosome arms, but did not affect the centromere/KT localization of 
PICH. Interestingly, the inhibition of Cdk1/2 did not affect the localization of PICH (Figure 20), 
supporting the result that the direct phosphorylation of PICH by Plk1 does not influence PICH 
localization. Surprisingly, co-inhibition of both kinases interfered with the chromosome arm 
recruitment of PICH and significantly enhanced the centromere/KT intensity of PICH (Figure 
20A). Western blot analysis revealed that the protein abundance of PICH was unaffected (Figure 
20B). This implies that centromere/KT levels of PICH increase in the absence of Cdk1/2/Plk1 
kinase activity. Conversely, it is possible that an increase in kinase activity might decrease PICH 
levels at centromeres/KTs. Thus, an equilibrium between the kinases Cdk1 and Plk1 and 
unknown phosphatases might regulate the localization of PICH at centromeres/KTs, even though 
this hypothesis has to be tested further. 
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Taken together, the kinase activities of Cdk1 and Plk1 seem to limit the localization of PICH at 
the centromeres/KTs. 
 
Figure 20: Dynamic localization of PICH depends on Cdk1 and Plk1. A) Immunofluorescence of HeLaS3 cells 
treated with TAL, roscovitine or in combination. Chromosome arm localization of PICH depends on Cdk1 and 
centromere/KT associated PICH is protected from Cdk1 and Plk1. Cells were synchronized with thymidine, released 
and directly supplemented with TAL. Roscovitine was added for 30min to mitotic cells. DNA (DAPI) is shown in 
blue, PICH is red and CREST in green. Scale bar represents 10µm. B) Western blot analysis of HeLaS3 cells treated 
as indicated. Protein abundance of PICH is unaffected in Cdk1 and Plk1 co-inhibition. 
 
4.2.3 Summary 
To understand the dynamic localization of PICH we generated mutants of PICH and performed 
rescue experiments. These experiments revealed that the TPR domains and the ATPase activity 
of PICH are important for its dissociation from chromosome arms. In addition, we identified the 
kinase activity of Plk1 as being indirectly required for the dynamic association of PICH with 
chromosome arms, but not required for the ATPase activity of PICH. Furthermore, we showed 
that the chromosome arm delocalization of PICH is independent of sister chromatid arm cohesin, 
leaving the Plk1 substrate unidentified that regulates the chromatin association of PICH. 
Moreover, we addressed possible mechanisms regulating the centromere/KT localization of 
PICH. Like PICH arm localization, centromere/KT-associated PICH localizes independently of 
centromeric cohesion. However, co-inhibition of Cdk1 and Plk1 revealed a function for both 
kinases in regulating the localization of PICH at the centromere/KT. 
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4.2.4 BEND3, a potential Plk1 substrate required for mitosis 
4.2.4.1 Identification of BEND3 
Although several members of the Snf2-family of helicases have been shown to function as multi-
subunit protein complexes (Cote et al., 1994; Ito et al., 1997; Shen et al., 2000), Plk1 is the only 
known binding partner of PICH so far. To identify new binding partners of PICH, we performed 
immunoprecipitation experiments of endogenous and overexpressed PICH. Besides Plk1 and 
ATP-dependent DNA and RNA helicases, members of the renal cell carcinoma (RCC) family 
and components of the BTR and FA complexes were identified (a complete list can be found in 
section 4.4 of the results). Additionally, we found the uncharacterized protein BEND3 (Figure 
21A) (also known as KIAA1553 or RP11-59I9.2). 
The coding sequence for BEND3 is located on chromosome 6q21 and comprises 2487 
nucleotides, resulting in a predicted protein of 828 amino acids. BLAST (NCBI) and PROSITE 
(ExPASy) sequence analysis revealed 4 BEN domains within the BEND3 protein sequence 
(Figure 21B). BEN domains are modules composed of 4 alpha-helices that can be found in 
several animal proteins like BANP/SMAR1 or NAC1 (Abhiman et al., 2008). The BEN domain 
is found in one or more copies in these proteins and was named after the experimentally 
characterized proteins BANP, E5R and NAC1 (BEN). Interestingly, the BEN domain is 
predicted to mediate protein-DNA and protein-protein interactions during chromatin 
organization and transcription (Abhiman et al., 2008). 
 
Figure 21: BEND3, a new binding partner of PICH. A) Protein sequence of human BEND3. Yellow highlighted 
peptides were found by mass-spectrometry after immunoprecipitation of PICH-WT and PICH-WAB. Depicted in 
green, cysteine residues modified with carbamidomethyl (due to sample preparation). B) ExPASy domain prediction 
of human BEND3. In addition, two conserved PBD binding sites were identified. 
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BEND3 belongs to the family of BEN domain containing proteins that differ in size and in the 
number of contained BEN domains (Figure 22). BEND1 (or BANP) is the only protein of the 
family that has been characterized to date and has been reported to function as a tumor 
suppressor (Birot et al., 2000; Kaul et al., 2003). 
 
Figure 22: BEN domain containing family of proteins. The human family of BEN domain-containing proteins. 
BEN domains are highlighted in blue. The size of the corresponding protein is indicated by the total amino acid (aa) 
number. BEND8 and BEND9 contain additional BTB domains, reported to mediate homodimerization (Bardwell 
and Treisman, 1994). 
 
4.2.4.2 BEND3 localizes to the chromatin during mitosis 
Because BEN domains are predicted to mediate protein-DNA interactions (Abhiman et al., 2008), 
we analyzed the intracellular distribution of BEND3. We generated a plasmid coding for human 
BEND3 and transfected HeLaS3 cells with this plasmid. The cells were arrested with nocodazole 
and analyzed by western blotting for the expression of exogenous BEND3. A prominent band of 
approximately 110kDa was detectable (Figure 23A), matching the calculated molecular weight 
of BEND3 of 94.49kDa in addition to the myc-tag. Next, we analyzed the mitotic localization of 
BEND3. We transiently transfected BEND3-myc into HeLaS3 cells, synchronized them in 
mitosis with nocodazole and performed immunofluorescence. Interestingly, BEND3-myc 
localized to mitotic chromosomes (Figure 23B), confirming a recent report in which BEND3 was 
found in a large scale proteomic analysis to be associated with mitotic chromatin (Ohta et al., 
2010). 
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Figure 23: BEND3 localizes to mitotic chromatin. A) Western blot analysis of HeLaS3 cell-lysates, transiently 
transfected with BEND3-myc. B) Immunofluorescence of nocodazole treated HeLaS3 cells, transiently transfected 
as indicated. BEND3 localizes to mitotic chromatin. DNA (DAPI) is shown in blue, BEND3 (myc) is shown in 
green and CREST in red. Scale bar represents 10µm. 
 
4.2.4.3 BEND3 deficiency leads to mitotic catastrophe 
Recently, BEND3 has been identified as a protein that associates with mitotic chromatin, but no 
functional predictions have been made (Ohta et al., 2010). To investigate the possible function of 
BEND3 in mitosis, we designed two siRNA duplexes specific for human BEND3. First, we 
analyzed the efficiency of the two siRNA duplexes. To this end, we transiently transfected 
HeLaS3 cells with BEND3-myc and the BEND3 siRNA duplexes. To avoid possible cell cycle 
effects of BEND3 depletion, we synchronized the cells with thymidine for the last 24hrs of 
transfection. Both siRNA duplexes significantly reduced the expression of exogenously 
expressed BEND3-myc, whereby the BEND3-2 siRNA duplex lead to a slightly better depletion 
(Figure 24A). Next, we analyzed the phenotype of BEND3 depletion. We transfected HeLaS3 
cells with the BEND3 siRNA duplexes and followed the cells by light microscopy. Interestingly, 
after 72hrs, BEND3 siRNA transfection resulted in a strong accumulation of dead cells (Figure 
24B), suggesting that BEND3 is essential for cell viability. 
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Figure 24: BEND3 siRNA duplexes are effective and BEND3 depletion induces cell death. A) Western blot 
analysis of HeLaS3 cell lysates, transiently transfected with BEND3-myc plasmid and the indicated BEND3 siRNA 
duplexes. Both BEND3 siRNA duplexes affect the protein level of exogenously expressed human BEND3. B) 
Light-microcopy images of HeLaS3 cells treated with the indicated siRNA duplexes. 72hrs of BEND3 depletion 
negatively affects cell viability. 
 
To analyze the phenotype of BEND3 depletion in more detail, we transfected HeLaS3 cells, 
stably expressing histone 2B-GFP, with a pool of both BEND3 siRNA duplexes and followed 
their cell cycle progression by time-lapse microscopy. Control cells entered mitosis, formed a 
metaphase plate and separated their chromatids properly. However, cells transfected with 
BEND3 siRNA duplexes entered mitosis, but were unable to align their chromosomes at the 
metaphase plate (Figure 25A). Furthermore, within a time period of 1.5hrs, approximately 60% 
of the cells underwent chromatin condensation and cell fragmentation, resulting in apoptosis and 
mitotic catastrophe (Figure 25B). This identifies BEND3 as an important protein for mitotic 
progression. 
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Figure 25: BEND3 is required for mitosis. A) Stills of representative HeLaS3 cells transfected with either Gl2 or 
BEND3 siRNA duplexes. Time represents progression through mitosis, starting with NEBD. Histone 2B-GFP 
shows chromatin and DIC the optical density. B) Bar graph showing the quantification of cells in A. 60% of 
BEND3-depleted cells are unable to progress through mitosis and undergo mitotic catastrophe. Error represents 
standard error from three individual experiments. 
 
4.2.4.4 BEND3 is a binding partner and potential substrate of Plk1 
In order to analyze a possible connection between PICH, Plk1 and BEND3, we asked whether 
BEND3 is a Plk1 substrate during mitosis. First, we analyzed whether BEND3 associates with 
Plk1 during mitosis. Interestingly, exogenously expressed BEND3-myc co-precipitated 
endogenous Plk1 (Figure 26A), suggesting an association of both proteins during mitosis. By 
analyzing the amino acid sequence of BEND3, we identified two potential binding sites for polo-
box binding domains (two SSP motifs, comprising residues 92-94 and 405-407). Future 
experiments will be needed to test whether these motives are required for the interaction with 
Plk1. Second, we asked whether BEND3 is a potential substrate of Plk1. To this end, we 
overexpressed BEND3-myc together with the hyperactive form of Plk1 (Plk1-T210D) and 
arrested the cells in mitosis. Interestingly, BEND3 showed a slower migrating form in SDS gels 
when Plk1-T210D was present (Figure 26B). The appearance of this form was due to the kinase 
activity of Plk1, as it was absent when cells were treated with the Plk1 inhibitor TAL. 
Furthermore, we bioinformatically identified 32 putative Plk1 phosphorylation sites within the 
sequence of BEND3 (Figure 26C). However, whether Plk1 indeed phosphorylates BEND3 
directly and whether this phosphorylation affects the chromatin localization of PICH remains to 
be tested. 
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Figure 26: BEND3, a new binding partner and potential substrate of Plk1. A) Western blot analysis after 
immunoprecipitation of exogenously expressed BEND3-myc. BEND3 interacts with Plk1. B) Western blot analysis 
of HEK293T cell-lysates transfected with indicated plasmids. Co-expression of hyperactive Plk1 induces a slower 
migrating band of BEND3 that is absent when Plk1 is inhibited by TAL. C) Amino acid sequence of BEND3. 
Highlighted in red and bold letters are putative Plk1 phosphorylation sites. Letters corresponding to the two polo-
box binding domains are underlined and shown in italic. 
 
4.2.4.5 The localization of PICH and Plk1 depends on BEND3 
Next, we analyzed whether the absence of BEND3 would affect the localization of PICH during 
mitosis. We transfected HeLaS3 cells with BEND3 siRNA duplexes and synchronized the cells 
by thymidine, followed by a 10hrs release prior to PTEMF fixation. Interestingly, in cells that 
had strong defects in aligning their chromosomes at the metaphase plate, PICH and Plk1 were 
undetectable at the centromere/KT (Figure 27A), suggesting a functional relationship between 
BEND3, PICH and Plk1. Western blot analysis of BEND3 siRNA-transfected HeLaS3 cell 
lysates revealed that the protein abundance of PICH and Plk1 was unaffected (Figure 27B), 
implying that PICH and Plk1 are delocalized rather than degraded in BEND3-depleted cells. To 
rule out that the architecture of the KT and the mitotic spindle is affected by BEND3 depletion, 
we analyzed the localization of Hec1 or alpha-Tubulin in BEND3 depleted cells, respectively. 
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We observed that Hec1 localization to the KT was not affected and that the mitotic spindles were 
bipolar (Figure 27C). Thus, BEND3 is required for the localization of PICH and Plk1 at the 
centromere/KT and that their requirement does not reflect a general defect in spindle architecture 
and KT structure. 
 
 
Figure 27: Centromere/KT PICH and Plk1 localization depends on BEND3 A) Immunofluorescence of HeLaS3 
cells transfected with either Gl2 or BEND3 siRNA duplexes. PICH and Plk1 delocalize from the centromere/KT 
upon BEND3 depletion. DNA was stained with DAPI; PICH is shown in red, Plk1 in green and CREST in blue. 
Scale represents 10µm. B) Western blot analysis of HeLaS3 cell lysates treated as indicated. The protein level of 
PICH and Plk1 are not affected by BEND3 depletion. C) Immunofluorescence of HeLaS3 cells transfected with 
either Gl2 or BEND3 siRNA duplexes. Hec1 and alpha-Tubulin localization is unaffected when BEND3 is absent. 
DNA was stained with DAPI; PICH is shown in red, alpha-Tubulin in green and Hec1 in blue. Scale represents 
10µm. 
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4.2.4.6 Summary 
To understand the association of PICH with mitotic chromatin in more detail, we performed 
immunoprecipitation of PICH followed by mass spectrometry. We identified the protein BEND3 
as a binding partner of PICH and characterized BEND3 as a member of the BEN domain 
containing family of proteins. Interestingly, BEND3 localizes to mitotic chromatin during 
mitosis and its depletion affects the alignment of chromosomes at the metaphase plate and 
subsequently results in apoptosis. Furthermore, we show that BEND3 is a binding partner and 
potential substrate of Plk1 during mitosis. Interestingly, BEND3 depletion leads to the 
delocalization of PICH and Plk1, but does not affect the structure of the mitotic spindle or the 
localization of Hec1 to KTs. We therefore hypothesize that Plk1 might phosphorylate BEND3 to 
regulated the localization of PICH during mitosis. 
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4.3 Functional characterization of PICH 
4.3.1 PICH is not required for the SAC 
Depletion of PICH with two independent siRNA duplexes had originally been shown to abolish a 
SAC-dependent mitotic arrest (Baumann et al., 2007). In addition, the essential SAC component 
Mad2 had been reported to delocalize from the KT upon PICH depletion (Baumann et al., 2007), 
implying that PICH has a function in the SAC. However, in a recent study these results had to be 
revised, as we could show that the originally used PICH siRNA duplexes also reduce the mRNA 
and protein levels of Mad2 (Hübner et al., 2009). Furthermore, several siRNA duplexes have 
subsequently been identified that effectively deplete PICH but do not affect Mad2 protein 
abundance or localization, thereby questioning the role of PICH in SAC signaling (Hübner et al., 
2009). To confirm that PICH does not function in SAC signaling and to explore the “real” 
function of PICH, we performed single-cell microinjection with antibodies that detect the native 
form of PICH; a monoclonal PICH antibody (mAB, characterized above, section 4.1) and a 
polyclonal antibody (pAB) specific for PICH (Baumann et al., 2007). 
Initially, we wanted to confirm that the SAC override by PICH depletion was only due to an off-
target effect on Mad2 mRNA. Thus, HeLaS3 cells were treated with nocodazole for 5hrs, 
microinjected and kept in culture for additional 3hrs prior to immunofluorescence. As expected, 
the injection of cells with antibodies targeting PICH or myc (negative control) did not lead to a 
mitotic exit in the presence of nocodazole (Figure 28, A and B), demonstrating the PICH 
independency of the SAC. In contrast, injection of a previously reported monoclonal Mad2 
antibody (positive control) completely abolished the mitotic arrest and lead to mitotic exit of 
injected cells (Chan et al., 2009b), confirming the importance of Mad2 for SAC signaling. 
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Figure 28: PICH does not function in the SAC. A) Immunofluorescence of antibody-microinjected HeLaS3 cells 
treated with nocodazole. PICH-antibody injection does not abolish a SAC-dependent arrest. B) Bar graph illustrating 
the quantification of A. Mad2 antibody injection significantly abolishes a nocodazole-induced SAC-dependent arrest 
in mitosis. Error bars represent standard error from three individual experiments. 
 
4.3.2 PICH deficiency results in chromatin bridges during anaphase 
Next, we set out to identify the potential role of PICH in mitotic progression. Recently, PICH has 
been shown to function in prometaphase chromosome arm architecture and cohesion (Kurasawa 
and Yu-Lee, 2010; Leng et al., 2008). However, the siRNA duplexes used in those studies have 
been shown to induce an off-target effect on Mad2 mRNA and protein levels (Hübner et al., 
2009). To circumvent this problem and elucidate the function of PICH at prometaphase 
chromosome arms we analyzed living cells microinjected with PICH antibodies by time-lapse 
microscopy. HeLaS3 cells stably expressing histone 2B-GFP were presynchronized in interphase 
with thymidine for 24hrs, released for 7hrs, then microinjected with different antibodies and 
subsequently monitored by time-lapse microscopy. The time between NEBD and the onset of 
anaphase slightly increased in all tested conditions (Figure 29B), most likely representing 
cellular stress due to the procedure of microinjection. However, PICH antibody injection did not 
affect the timing of anaphase-onset, compared to the control antibody, confirming that the SAC 
is independent of PICH (Figure 29, A and B). Most interestingly, PICH antibody-injected cells 
showed a significant increase in chromatin bridges during anaphase (control AB: 3-5%, PICH 
AB: 18-19%) (Figure 29, A and C), which implies a role for PICH in faithful sister chromatid 
segregation. 
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To confirm that PICH deficiency leads to chromatin bridges during anaphase, we also depleted 
PICH with specific siRNA duplexes and analyzed the cells by time-lapse microscopy. For these 
experiments we used siRNA duplexes that have recently been shown to efficiently deplete PICH 
without affecting SAC signaling (Hübner et al., 2009). HeLaS3 cells stably expressing histone 
2B-mCherry were transfected with PICH siRNA duplexes for 48hrs, synchronized with 
thymidine for 24hrs, released for 7hrs and analyzed by time-lapse microscopy. Similar to the 
result obtained by antibody injection, PICH knockdown did not accelerate the time required from 
NEBD to anaphase onset (Figure 30, A and B). However, PICH depletion resulted in a 
significant increase in chromatin bridges during anaphase compared to control cells (27% and 
5%, respectively) (Figure 30, A and C), confirming that PICH functions in the faithful 
segregation of chromosomes during mitosis. 
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Figure 29: PICH antibody injection leads to chromatin bridges during anaphase. A) Stills of representative 
HeLaS3 cells microinjected with indicated antibodies. Time represents progression through mitosis, starting with 
NEBD. Histone 2B-GFP shows chromatin, DIC shows optical density and Texas-Red indicates positive injection. 
Arrows highlight chromatin bridges during anaphase. B) Box-and-whisker plot illustrating the quantification of 
mitotic progression of A. PICH neutralization does not accelerate mitotic progression. (N.I.: not injected, C.I.: 
control injected, P.I.: PICH injected) C) Bar graph showing the quantification of chromatin bridges of A. PICH 
antibody injection results in chromatin bridges during mitosis. Error bars represent standard error from three 
individual experiments. 
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Figure 30: PICH knockdown results in chromatin bridges during anaphase. A) Stills of representative HeLaS3 
cells transfected with either Gl2 or PICH siRNA duplexes. Time represents progression through mitosis, starting 
with NEBD. Histone 2B-mCherry shows chromatin and DIC the optical density. Arrows indicate chromatin bridges 
during anaphase. B) Box-and-whisker plot showing the quantification of mitotic progression of A. PICH knockdown 
does not accelerate mitotic progression. C) Bar graph showing the quantification of chromatin bridges of A. PICH 
knockdown results in chromatin bridges during mitosis. Error bars represent standard error from three individual 
experiments. 
 
To visualize the segregation defect of mitotic chromosomes upon PICH knockdown in more 
detail, we analyzed anaphase cells of fixed PICH-depleted HeLaS3 cells. The analyzed cells 
revealed a broad heterogeneity in the number of chromatin bridges, from one single to multiple 
chromatin bridges per cell (Figure 31). 
 
Figure 31: Heterogeneity of PICH depletion-induced chromatin bridges. Representative images of HeLaS3 
anaphase cells depleted of PICH for 48hrs. PICH deficiency can lead to multiple chromatin bridges during anaphase. 
Chromatin stained with DAPI. Scale bar represents 10µm. 
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4.3.3 PICH depletion results in the formation of micronuclei 
We have shown that PICH deficiency can lead to the formation of chromatin bridges during 
anaphase. Previously, chromatin bridges have been shown to break into multiple fragments at the 
end of mitosis, promoting the formation of micronuclei (MN) (Hoffelder et al., 2004; Naim and 
Rosselli, 2009a; Rosin and German, 1985; Utani et al., 2010). Therefore, we analyzed the 
frequency of MN in asynchronously growing PICH-depleted HeLaS3 cells. In contrast to Gl2 
transfection, PICH depletion resulted in a significant increase of MN (0.92% to 4.19%, 
respectively) (Figure 32, A and B). This strongly suggests that PICH-deficiency induced 
chromatin bridges break into fragments and form MN. 
 
Figure 32: PICH depletion-induced chromatin bridges promote MN formation. A) Representative images of 
HeLaS3 interphase cells depleted of PICH for 48hrs. Chromatin was stained with DAPI. Arrows indicate MN. B) 
Bar graph illustrating the quantification of A. PICH deficiency promotes MN formation. Error bars represent 
standard error from three individual experiments. 
 
4.3.4 The ATPase activity of PICH is indispensable to prevent the formation of chromatin 
bridges 
We have shown that PICH exhibits ATPase activity in vitro that depends on the classical Walker 
A and Walker B motives (section 4.2.1.3). Furthermore, neutralization or knockdown of PICH 
results in the formation of chromatin bridges (section 4.3.2-3). To ask whether the ATPase 
activity of PICH is required for chromatin bridge resolution, we performed rescue experiments 
coupled to time-lapse microscopy. Interestingly, the transient expression of wild-type but not 
ATPase-dead PICH prevented the formation of chromatin bridges during anaphase (2% and 32%, 
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respectively) (Figure 33, A and B). Thus, the ATPase activity of PICH is indispensable to 
prevent the formation of chromatin bridges during anaphase. 
Recently, it has been shown that PICH localization to chromosome arms (and bound Plk1) 
contribute to prometaphase chromosome arm architecture (Kurasawa and Yu-Lee, 2010). As 
impaired chromosome arm architecture can result in chromatin bridges, we asked whether the 
PICH-Plk1 interaction is required to prevent the formation of chromatin bridges. We mutated the 
Plk1 docking site of PICH and performed time-lapse microscopy of cells expressing mutant 
PICH protein in a siRNA background. To mimic the phosphorylation at threonine 1063 and 
promote a stable interaction between PICH and Plk1, we mutated threonine 1063 to aspartic (TE) 
and glutamic acid (TD). Unfortunately, neither PICH-TE nor PICH-TD interacted with Plk1 
(Figure 34, A and B), making rescue experiments with these constructs impossible. In contrast, 
PICH-TA prevented the formation of chromatin bridges (Figure 33, A and B), in spite of its 
inability to bind Plk1 (Figure 34B). The chromatin-bridge rescue exerted by PICH-TA still 
required the ATPase activity of PICH, as PICH-WAB-TA (ATPase inactive and unable to bind 
Plk1) was unable to prevent the formation of chromatin bridges during anaphase (Figure 33, A 
and B). These data demonstrate that the interaction between PICH and Plk1 is not required to 
prevent chromatin bridges during anaphase, but they do not exclude the possibility that the 
disruption of this interaction is required. 
The above experiment also revealed that, towards the end of mitosis, the dissociation of ATPase-
dead PICH from the chromatin was significantly prolonged compared to PICH-WT (90 min to 
26 min, respectively) (Figure 33, A and C). Therefore, we asked whether ATPase-dead PICH 
affects the exit of mitosis. To answer this question, we analyzed the reformation of the nuclear 
envelope in cells expressing ATPase-dead PICH. In contrast to wild-type PICH, ATPase-dead 
PICH colocalized with the chromatin even after the nuclear envelope had reformed (Figure 34C), 
demonstrating that mitotic exit had occurred, even though PICH still associated with chromatin. 
Interestingly, in this experimental set-up, chromatin bridges were induced by overexpression of 
ATPase-dead PICH despite the presence of endogenous PICH. This demonstrates that ATPase-
dead PICH acts antagonistically to endogenous PICH like a dominant negative mutant of PICH. 
Thus, the ATPase activity of PICH is essential for the resolution of chromatin bridges during 
anaphase, but this activity is independent of the interaction between PICH and Plk1. 
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Figure 33: The ATPase activity of PICH is indispensable to prevent chromatin bridges during anaphase. A) 
Stills of representative HeLaS3 cells transfected with PICH siRNA duplexes and siRNA refractory PICH plasmids. 
Time represents progression through mitosis, starting with anaphase onset. Histone 2B-mCherry shows chromatin 
and DIC the optical density. Arrows indicate chromatin bridges during anaphase. B) Bar graph illustrating the 
occurrence of chromatin bridges of cells in A. Error bars represent standard error from three individual experiments. 
C) Box-and-whisker plot showing the quantification of the time required from anaphase onset until the chromatin 
dissociation of indicated PICH species. 
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Figure 34: ATPase-dead PICH does not interfere with mitotic exit. A) Western blot analysis of HEK293T cell 
lysates, treated as indicated. PICH mutants generated to mimic phosphorylation at threonine 1063 are no substrate 
for Plk1 during mitosis. B) Western blot analysis of immunoprecipitated PICH species. PICH mimic mutants are 
unable to bind Plk1. C) Immunofluorescence of HeLaS3 cells transiently transfected with indicated PICH constructs. 
ATPase-dead PICH stays associated with the chromatin even after the nuclear envelop has reformed. Arrow 
indicates chromatin bridges. DNA stained with DAPI, gfp is shown green, Lamin A+B2 in red and CREST in blue. 
Scale bar represents 10µm. 
 
4.3.5 Sequestration of Plk1 by PICH and consequences for mitotic progression 
We have shown that the ATPase activity of PICH is required to prevent the formation of 
chromatin bridges during mitosis (section 4.3.4). We also observed a striking increase in the time 
from NEBD until anaphase onset (by 3 fold; from 30min to 95min) (Figure 35B) when 
constructs of PICH were expressed that bind Plk1 (PICH-WT and PICH-WAB) compared to 
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those that do not bind Plk1 (PICH-TA and PICH-WAB-TA) (Figure 35A). In addition, only 58-
60% of those cells exited mitosis, while the others remained arrested at prometaphase until the 
end of filming or died (Figure 35C). Interestingly, the fate of a single transfected cell correlated 
with the level of overexpressed protein, as analyzed by GFP signal intensity, during 
prometaphase. Strong expression of PICH-WT correlated with a mitotic arrest, whereas low 
expression correlated with mitotic exit (Figure 35D). 
 
Figure 35: Expression level of PICH determines the fate of a mitotic cell. A) Western blot analysis of 
immunoprecipitated PICH species overexpressed in HEK293T cells. Mutation of threonine 1063 abolishes binding 
to Plk1. B) Box-and-whisker plot illustrating the time required from NEBD until anaphase onset for individual PICH 
species. PICH-WT and PICH-WAB prolong mitotic progression. C) Bar graph showing the percentage of cells that 
is able to exit from mitosis when different PICH species are expressed. Error bars represent standard error from 
three individual experiments. D) Box-and-whisker plot illustrating the GFP intensities of PICH-WT and PICH-TA 
expressing cells with respect to their fate in mitosis. The expression level of PICH determines the fate of a mitotic 
cell. 
 
The delay in mitotic progression induced by PICH overexpression is very similar to the 
phenotype of Plk1 depletion or inhibition (Santamaria et al., 2007; Sumara et al., 2004). We thus 
hypothesize that PICH sequesters Plk1, thereby promoting the delay in mitotic progression. 
During early mitosis, PICH and Plk1 colocalize to the centromere/KT of condensed mitotic 
RESULTS 
53 
chromosomes, making this stage unfeasible to analyze a potential sequestration of Plk1 by PICH. 
However, during anaphase, Plk1 localizes to the central spindle, whereas PICH localizes to the 
centromere/KT and UFBs. Therefore, we analyzed whether the transient overexpression of 
PICH-WT or PICH-TA affects the localization of Plk1 during anaphase. In contrast to PICH-TA, 
PICH-WT recruited Plk1 to the centromere/KT of separating chromatids during anaphase 
(Figure 36A, upper panel). However, during telophase, Plk1 localized exclusively to the 
midbody even in cells overexpressing PICH (Figure 36A, lower panel), arguing that the 
interaction of PICH and Plk1 was abolished at that stage. Immunoprecipitation of endogenous 
PICH revealed that the disassembly of PICH-Plk1 correlates with the degradation of cyclin B1 
and interference with anaphase-onset (mg132 treatment) stabilizes this interaction (Figure 36B). 
Thus, these data demonstrate that the transient overexpression of PICH affects the localization of 
Plk1 during anaphase, implying a sequestration of Plk1 by PICH during mitosis. 
 
Figure 36: Overexpressed PICH sequesters Plk1. A) Immunofluorescence of HeLaS3 cells transiently transfected 
with PICH-WT and PICH-TA. PICH-WT recruits Plk1 to the centromere/KT of separating chromatids. DNA 
stained with DAPI, PICH (gfp) is shown in green, Plk1 in red and CREST in blue. Scale bar represents 10µm. B) 
Western blot of immunoprecipitated PICH after nocodazole release. PICH Plk1 disassembly correlates with cyclin 
B1 degradation and anaphase onset. 
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4.3.6 PICH-induced chromatin bridges arise at non-centromeric loci 
During anaphase, PICH localizes to UFBs connecting the separating centromere/KTs of 
chromatids (Baumann et al., 2007). These PICH-positive UFBs have been shown to consist of 
centromeric DNA (Wang et al., 2008), therefore we will refer to them as centromeric UFBs. 
Interestingly, the resolution of centromeric UFBs during anaphase requires the activity of a type 
2 topoisomerase (Baumann et al., 2007), arguing that centromeric UFBs most likely represent 
fully replicated but still catenated DNA strands (for review see Wang, 2002). Recently, PICH 
positive non-centromeric UFBs have been identified by colocalization of PICH with FA-family 
members (FANCD2 and FANCI) and the BTR complex (Chan et al., 2007; Chan et al., 2009a; 
Hutchins et al., 2010; Naim and Rosselli, 2009a). Both, FA-family members and the BTR 
complex have been shown to contribute to DNA repair and act most likely synergistically 
(Knipscheer et al., 2009; Meetei et al., 2003; Pichierri et al., 2004; Wu and Hickson, 2003). 
Therefore, we asked whether the chromatin bridges that we observed when PICH was depleted 
originate from centromeric or non-centromeric loci. We performed rescue experiments and 
analyzed the existence of centromeric UFBs in early and late anaphase cells by costaining the 
cells with CREST to visualize the centromere for immunofluorescence. In early anaphase, PICH-
WT and PICH-WAB localized to centromeric UFBs that were flanked by CREST (Figure 37A). 
In late anaphase, however, these centromeric UFBs were absent in both PICH-WT and PICH-
WAB-expressing cells (Figure 37, A and B). This suggests that centromeric UFBs are resolved 
independently of the PICH ATPase activity during anaphase. 
In contrast to wild-type, PICH-WAB localized to non-centromeric UFBs, determined by the lack 
of CREST signal (Figure 37A). In line with this, late anaphase cells that expressed PICH-WAB 
developed chromatin bridges (Figure 37, A and C). Thus, non-centromeric loci are probably the 
source of the chromatin bridges in late anaphase. In an unperturbed anaphase, spindle forces pull 
the sister chromatids to the poles in a fashion that the centromere/KTs are separated in an aligned 
conformation. The PICH-WAB induced chromatin bridges strongly affected this aligned 
conformation, as the centromere/KTs were often detected within or at the ends of the chromatin 
bridges (Figure 37A), also implying that non-centromeric loci lead to chromatin bridges. 
Furthermore, the depletion of Sgo1 has been shown to induce premature sister chromatid 
separation and to increase the number of PICH-positive centromeric UFBs (Baumann et al., 2007; 
McGuinness et al., 2005). Interestingly, when Sgo1 is depleted, PICH-positive centromeric 
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UFBs can reach lengths of several µm without inducing chromatin bridges (Figure 37D). 
Together these data demonstrate that chromatin bridges induced by PICH depletion do not result 
from centromeric loci, but most likely result from non-centromeric loci. 
 
Figure 37: PICH deficiency-induced chromatin bridges arise from non-centromeric loci. A) 
Immunofluorescence of HeLaS3 cells transiently transfected with PICH siRNA and siRNA-refractory plasmids 
coding for PICH-WT and PICH-WAB. PICH-WT and PICH-WAB localize to centromeric UFBs in early but not 
late anaphase. PICH-WAB localizes to non-centromeric bridges connecting chromatids. Centromere/KTs are often 
detected within chromatin bridges (asterisks). DNA stained with DAPI (blue), PICH (gfp) is shown in green and 
CREST in red. Scale bar represents 10µm. B-C) Bar graphs illustrating the decrease in centromeric UFBs 
throughout anaphase and the induction of chromatin bridges by PICH-WAB in late anaphase cells. Error bars 
represent standard error from three individual experiments. D) Immunofluorescence of Sgo1 depleted HeLaS3 cells. 
PICH-positive centromeric UFBs can reach lengths of several µm without inducing chromatin bridging. DNA 
stained with DAPI (blue), PICH is shown in red and CREST in green. Scale bar represents 10µm. 
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4.3.7 PICH interacts with and regulates the localization of the BTR complex 
In a systematic approach performed to identify protein complexes that form during mitosis, 
PICH was identified as a binding partner of the BTR complex (Hutchins et al., 2010). In that 
study, PICH, but not Plk1, was shown to interact with the BTR complex, suggesting that PICH 
interacts in a mutually exclusive manner with either Plk1 or the BTR complex. Furthermore, 
PICH was reported to colocalize with the BTR complex to non-centromeric UFBs that are 
flanked by the FA-family member FANCD2 (Chan et al., 2007; Chan et al., 2009a; Naim and 
Rosselli, 2009a). FANCD2 associates specifically with fragile site loci and presumably marks 
abnormally intertwined DNA structures induced by replication stress (Chan et al., 2009a; Naim 
and Rosselli, 2009a). Interestingly, the number of FANCD2-flanked PICH-BLM-positive UFBs 
is significantly increased, when cells are exposed to aphidicolin prior to mitosis (Chan et al., 
2009a; Naim and Rosselli, 2009a), suggesting a common function for PICH and BLM after DNA 
damage. In addition, in an in vitro assay PICH is able move stalled replication folks (Dr. Lily 
Wang, personal communication), that form in the presence of aphidicolin. 
To better understand the relationship between PICH and the BTR complex/FA family, we 
initially performed immunoprecipitation experiments, isolating overexpressed PICH-WT and 
PICH-WAB from nocodazole-arrested HEK293T cells. Surprisingly, only PICH-WAB was able 
to co-precipitate the BTR complex and the FA-family member FANCG (Table 4 and Figure 38). 
This suggests that the ATPase activity of PICH negatively regulates the association with the 
BTR complex. The BTR component BLM localizes to the cytoplasm during early mitosis and to 
a subset of UFBs upon anaphase onset. Because PICH-WAB interacts with the BTR complex 
prior to anaphase, we asked whether exogenous PICH-WAB would affect the sub-cellular 
localization of BLM during early mitosis. We transiently transfected HeLaS3 cells with PICH-
WT or PICH-WAB and arrested the cells at prometaphase with nocodazole. In contrast to PICH-
WT, PICH-WAB recruited endogenous BLM to distinct loci that did not colocalize with CREST 
(Figure 39, blow-ups), further demonstrating that the ATPase activity of PICH regulates the 
association with the BTR complex and that ATPase-inactive PICH is able to recruit BLM. 
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Figure 38: PICH interacts with the BTR complex; peptides identified by mass spectrometry. Protein sequence 
of the human BLM helicase. Yellow highlighted peptides were found by mass-spectrometry after 
immunoprecipitation of PICH-WAB. Depicted in green, cysteine residues modified with carbamidomethyl (due to 
sample preparation). 
 
Table 4: ATPase-dead PICH interacts with the BTR complex. ATPase-dead PICH, but not ATPase-active PICH, 
interacts with the BTR complex and members of FA-family prior to anaphase. (n.d.: not determined) 
IP of Plk1 BTR complex FA-member BLM TOP3A RMI1 
PICH-WT + n.d. n.d. n.d. n.d. 
PICH-WAB + + + n.d. + 
 
 
Figure 39: ATPase-dead PICH recruits BLM prior to anaphase. Immunofluorescence of HeLaS3 cells, 
transiently transfected with PICH-WT or PICH-WAB and arrested in prometaphase by nocodazole. ATPase-dead 
PICH recruits BLM to loci of high PICH localization during prometaphase. Blow-ups highlight the recruitment of 
BLM by PICH-WAB to sites distinct from CREST positive centromeres. DNA was stained with DAPI, PICH (gfp) 
is shown in green, BLM in red and CREST in blue. Scale bar represents 10µm. 
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Given that, ATPase-dead PICH is able to recruit BLM during prophase we asked whether BLM 
would colocalize to chromatin bridges that are induced by PICH-WAB during anaphase. 
Although BLM could not be detected on bridges themselves, it often localized to the ends of 
PICH positive chromatin bridges (Figure 40), suggesting a recruitment of BLM to the termini of 
PICH-WAB induced chromatin bridges. 
Cells derived from Bloom-syndrome patients (BLM inactive) or depleted of endogenous BLM 
have been shown to develop chromatin bridges during anaphase (Chan et al., 2007), 
demonstrating that BLM is required for the faithful segregation of chromatids during mitosis. 
Thus, PICH and the BTR complex may act synergistically to prevent chromatin bridges during 
mitosis. 
 
Figure 40: BLM localizes to chromatin bridges. Immunofluorescence of HeLaS3 cells transiently transfected with 
PICH-WAB. BLM colocalizes with PICH to chromatin bridges. Blow-ups highlight the colocalization of BLM to 
PICH-WAB induced chromatin bridges. DNA was stained with DAPI, PICH (gfp) is shown in green, BLM in red 
and CREST in blue. Scale bar represents 10µm. Asterisks point to a frequently observed PICH-gfp aggregate, to 
which BLM is recruited. 
 
4.3.8 Rif1, a new binding partner of PICH 
In addition to the BTR complex we found that both PICH-WT and PICH-WAB associated with 
Rif1 during mitosis. The RAP1-interacting factor, Rif1, was first identified in budding and 
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fission yeast for regulating the length of telomeres (Hardy et al., 1992). In contrast to the yeast 
ortholog, however, human Rif1 does not regulate the length of telomeres (Xu and Blackburn, 
2004). Instead, human Rif1 was shown to function downstream of ATM and 53BP1 in the S-
phase checkpoint after DNA-damage (Silverman et al., 2004), contributing to cell survival after 
replication stress and to homology-directed DNA-damage repair (Buonomo et al., 2009). 
Interestingly, immunofluorescence of human Rif1 revealed its localization along fiber-like 
structures during anaphase that diminish as anaphase progresses (Xu and Blackburn, 2004). 
Moreover, human Rif1 interacts with and provides a DNA-binding interface for the BTR 
complex to restart stalled replication forks to allow normal replication (Xu et al., 2010). 
Considering that human Rif1 interacts with the BTR complex and localizes to structures 
reminiscent of PICH-positive UFBs during anaphase, it is intriguingly that we identified human 
Rif1 as a new interaction partner of PICH. Mass spectrometry in fact identified 13 unique 
peptides (7.1% sequence coverage) of Rif1 in PICH immunoprecipitates. 
Next, we asked whether Rif1 colocalizes with PICH during the cell cycle. To this end, we 
performed immunofluorescence of HeLaS3 cells and stained for PICH and Rif1 (antibody kindly 
provided by Dr. Weidong Wang, (Xu et al., 2010)). Even though the localization of Rif1 during 
the cell cycle had been studied previously, a potential co-localization with PICH had never been 
analyzed (Silverman et al., 2004; Xu and Blackburn, 2004). During interphase, Rif1 localized to 
the nuclear envelope and the nucleoplasm (Figure 42). In early mitosis, Rif1 then localized 
weakly to the centromere/KT. From early anaphase on Rif1 was prominent at fiber-like 
structures that colocalized with PICH. This localization diminished during anaphase until Rif1 
became reassociated with the nuclear envelope and the chromatin during late mitosis (Figure 42). 
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Figure 42: Mitotic localization of Rif1. Immunofluorescence of HeLaS3 cells. Rif1 localizes to the nuclear 
envelope during interphase. During early mitosis, Rif1 localizes weakly to the centromere/KT (arrow) until it 
localizes at fiber-like structures that colocalize with PICH during anaphase. In late mitosis, Rif1 localizes to the 
nuclear envelope and the chromatin. DNA stained with DAPI, Rif1 is shown in green, PICH in red and CREST in 
blue. Scale bars represent 10µm. 
 
Furthermore, we depleted Sgo1 in HeLaS3 cells to increase the amount the centromeric UFBs 
and subsequently performed immunofluorescence for Rif1 and PICH. We observed that Rif1 
completely colocalized with PICH to centromeric UFBs (Figure 43). These results demonstrate 
that the Rif1 fiber-like structures are not microtubule-associated structures, as had been 
hypothesized earlier (Xu and Blackburn, 2004), but are PICH-positive centromeric UFBs. 
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Figure 43: Rif1 localizes to PICH-positive centromeric UFBs. Immunofluorescence of HeLaS3 cells transfected 
with either Gl2 or Sgo1 siRNA duplexes. Rif1 colocalizes with PICH to centromeric UFBs during early anaphase. 
Blow-ups represent a 2.5 fold magnification of the white marked area. Note the exact colocalization of Rif1 with 
PICH. DNA stained with DAPI, Rif1 is shown in green, PICH in red and CREST in blue. Scale bar represents 10µm. 
 
Recently, Rif1 has been shown to be a new component of the BTR complex whose function is 
required for faithful DNA replication (Xu et al., 2010). In particular, Rif1 provides a new DNA-
binding interface for the BTR complex to promote the recovery of stalled replication forks (Xu et 
al., 2010). As PICH interacts with and regulates the localization of the BTR complex (see section 
4.3.7 of this work and a previous study (Hutchins et al., 2010)), we hypothesize that PICH 
regulates the localization of the BTR complex via the interaction with Rif1. To address this, we 
depleted PICH from HeLaS3 cells and analyzed the localization of Rif1 in anaphase cells. In 
contrast to control-treated cells, Rif1 did not localize to UFBs in anaphase when PICH was 
depleted (Figure 44A), suggesting that PICH is essential for the anaphase UFB localization of 
Rif1. In addition, when PICH was depleted, Rif1 stayed associated with the centromere/KT 
during anaphase until it localizes to the nuclear envelope and the chromatin in late mitosis 
(Figure 44B). Thus, PICH regulates the localization of Rif1 to centromeric UFBs. 
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Figure 44: PICH regulates the centromeric UFB localization of Rif1. A) Immunofluorescence of HeLaS3 cells 
transfected with either Gl2 or PICH siRNA duplexes. Centromeric UFB localization of Rif1 is regulated by PICH. B) 
Immunofluorescence of HeLaS3 cells transfected with PICH siRNA duplexes. Rif1 stays associated with the 
centromere/KT during anaphase when PICH is depleted. A+B) DNA stained with DAPI, Rif1 is shown in green, 
PICH in red and CREST in blue. Scale bars represent 10µm. 
 
During interphase Rif1 and the BTR complex are recruited to foci of DNA damage in an ATM 
kinase- and 53BP1-dependent manner (Silverman et al., 2004; Xu et al., 2010; Xu and Blackburn, 
2004). As we have shown that PICH interacts with both Rif1 and the BTR complex during 
mitosis, we asked whether PICH is recruited to these interphase foci of DNA damage as well, 
even though normally PICH localizes to the cytoplasm in undamaged cells (Baumann et al., 
2007). We induced DNA-damage by methyl-methan-sulfonate (MMS; induction of stalled 
replication forks) and mitomycin-c (MMC; induction of interstrand crosslinks) and analyzed the 
localization of PICH and Rif1 by immunofluorescence. Since in HeLaS3 cells p53 is inactivated 
(by the action of the HPV-encoded E6 oncoprotein) we analyzed the effect of MMS and MMC in 
both HeLaS3 and p53-positive U2OS cells. Both treatments induced a strong recruitment of Rif1 
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to DNA-damage foci in HeLaS3 as well as U2OS cells (Figure 45, A and B), confirming 
previous work (Xu and Blackburn, 2004). However, PICH was not recruited to these DNA-
damage foci (Figure 45, A and B). Thus, PICH is not recruited to sites of stalled replication forks 
or interstrand crosslinks during interphase, suggesting that PICH does not to function in 
interphase DNA-damage repair. 
 
Figure 45: PICH does not localize to foci of DNA damage during interphase. A) Immunofluorescence of 
HeLaS3 and U2OS cells treated with 0.02% MMS for 1 hr. B) Immunofluorescence of HeLaS3 and U2OS cells 
treated with 120ng/µL MMC for 20hrs. A+B) PICH is not recruited to foci of DNA-damage. DNA stained with 
DAPI, Rif1 is shown in green, PICH in red and CREST in blue. Scale bars represent 10µm. 
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4.3.9 Summary 
Both PICH and co-targeted Plk1 have been shown previously to function in prometaphase 
chromosome arm architecture and cohesion (Kurasawa and Yu-Lee, 2010; Leng et al., 2008). 
However, the siRNA duplexes used in both previous studies have recently been shown to also 
affect the SAC component Mad2, resulting in checkpoint failure (Hübner et al., 2009). In order 
to understand the mitotic function of PICH independently of off-target effects, we performed 
both antibody microinjection and siRNA transfections using siRNA duplexes that specifically 
target PICH, followed by time-lapse microscopy. We confirmed that PICH does not function in 
SAC signaling and showed instead that PICH deficiency results in the formation of chromatin 
bridges during anaphase. Additionally, we identified the ATPase activity of PICH as being 
essential to resolve chromatin bridges, which are likely to emerge from non-centromeric 
chromatin. 
We have also shown that PICH interacts with and regulates the localization of the BTR complex, 
which has been shown to suppress chromosomal instability (Payne and Hickson, 2009). 
Furthermore, ATPase-inactive PICH recruits the BTR complex to chromatin bridges, suggesting 
a synergistic function at these structures. In addition, we identified the new PICH-binding 
protein Rif1, whose localization to centromeric UFBs depends on PICH. However, the function 
of PICH seems to be limited to mitosis, as PICH does not localize to sites of DNA damage 
during interphase that are positive for the BTR complex or Rif1. Thus, PICH, Rif1 and BLM 
may act in a complex to prevent chromatin bridge formation during mitosis, thereby suppressing 
chromosomal instability and maintain the integrity of the genome. 
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4.4 Tables, summarizing potential PICH binding partner and PICH phosphorylation sites 
A summary of PICH-binding partners that have been identified by mass spectrometry in this 
study is listed below. In short, we identified members of the BTR complex, confirming 
independent results (Hutchins et al., 2010). In addition, we found several proteins know to 
function in DNA repair (e.g. KU70, KU86, RIF1 and CHK1) or DNA and RNA processing (e.g. 
RCC1, RCC2, FUBP2, DHX15, NONO). Interestingly, we also identified proteins with so far 
unknown functions (e.g. BEND3). 
Table 5: Table, summarizing potential PICH binding partner found by mass spectrometry. Binding partners 
that have been known already are highlighted in bold letters. Binding partners of potential interest are highlighted in 
cursive letters. Members of the BTR complex and FA complex interact specifically with ATPase-dead PICH. Rif1 
interacts with both PICH-WT and PICH-WAB. 
No. Name (Accession no.) MW 
(No. of unique peptides found) 
PICH-
WT 
PICH-
WAB 
empty-
myc 
1 sp|Q2NKX8|ERC6L_HUMAN 141 kDa 186 403  
2 sp|P53350|PLK1_HUMAN 68 kDa 40 51  
3 sp|Q5T5X7|BEND3_HUMAN 94 kDa 7 8 0 
4 sp|Q5UIP0|RIF1_HUMAN 274 kDa 9 7 1 
5 sp|Q92945|FUBP2_HUMAN 73 kDa 4 5 1 
6 sp|P26599|PTBP1_HUMAN 57 kDa 6 5 1 
7 sp|P31689|DNJA1_HUMAN 45 kDa 3 5 1 
8 sp|O14965|STK6_HUMAN 46 kDa 1 4  
9 sp|P14635|CCNB1_HUMAN 48 kDa  4  
10 sp|P26641|EF1G_HUMAN 50 kDa 3 4 2 
11 sp|P23246|SFPQ_HUMAN 76 kDa 3 4 0 
12 sp|P06493|CDC2_HUMAN 34 kDa  4  
13 sp|P54132|BLM_HUMAN 159 kDa  4  
14 sp|Q9Y230|RUVB2_HUMAN 51 kDa 1 3  
15 sp|O14757|CHK1_HUMAN 54 kDa  3  
16 sp|Q9P258|RCC2_HUMAN 56 kDa 7 3 1 
17 sp|O43143|DHX15_HUMAN 91 kDa 6 3  
18 sp|Q9Y265|RUVB1_HUMAN 50 kDa 2 3  
19 sp|P63241|IF5A1_HUMAN 17 kDa 2 3 1 
20 sp|P28482|MK01_HUMAN 41 kDa 1 3  
21 sp|P31040|DHSA_HUMAN 73 kDa 1 3  
22 sp|P06737|PYGL_HUMAN 97 kDa 3 3 1 
23 sp|Q96QK1|VPS35_HUMAN 92 kDa 1 3  
24 sp|O75663|TIPRL_HUMAN 31 kDa 3 2  
25 sp|P12956|KU70_HUMAN 70 kDa 3 2  
26 sp|P13010|KU86_HUMAN 83 kDa 5 1  
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27 sp|O43684|BUB3_HUMAN 37 kDa 4 2  
28 sp|Q15058|KIF14_HUMAN 186 kDa 1 2  
29 sp|Q15233|NONO_HUMAN 54 kDa 3 2  
30 sp|Q8WXX5|DNJC9_HUMAN 30 kDa 2 2  
31 sp|Q9HB71|CYBP_HUMAN 26 kDa 2 2  
32 sp|Q9BQG0|MBB1A_HUMAN 149 kDa 2 2  
33 sp|P55265|DSRAD_HUMAN 136 kDa 4 1 0 
34 sp|P36873|PP1G_HUMAN 37 kDa 2 1  
35 sp|Q13148|TADBP_HUMAN 45 kDa 2 1  
36 sp|P63244|GBLP_HUMAN 35 kDa 4 1  
37 sp|P24534|EF1B_HUMAN 25 kDa 2 1  
38 sp|P18754|RCC1_HUMAN 45 kDa 3 0  
39 sp|Q13472|TOP3A_HUMAN 112 kDa  1  
40 sp|O15287|FANCG_HUMAN 69 kDa 1   
 
The next two tables summarize the phosphorylation sites of PICH that have been identified by 
mass spectrometry. 
Table 6: Table, summarizing phosphorylation sites of PICH identified by mass spectrometry. The first section 
compares thymidine- (interphase) and nocodazole- (mitosis) arrested cells by SILAC. The second section compares 
PICH-WT to PICH-TA in nocodazole-arrested cells. The PICH-PBD is highlighted in red. Abbreviations: mouse 
(m), xenopus (x), C. elegans (c), drosophila (d) and zebrafish (z). 
Site Conservation Found in PICH-WT PICH-TA Interphase Mitosis 
T 763 m, x   1  
S 774 m, x  + 5  
S 790 m  + 1 1 
T 797 m   1 1 
T 798    1  
T 805   + 2 2 
S 807    6 1 
S 810   + 4 1 
T 813    1  
S 820 m, x, c + + 4 5 
S 829  + + 1  
S 864 m, z   4  
S 946 c   1  
S 960 m, x, c   1  
S 968 m, c   1 1 
S 969 m   2  
S 971 c, z   3 2 
S 980 m, x, d   2 1 
S 984    2  
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S 995 m, c  + 1  
S 1000 m, x   1  
S 1028 m, x, c, z + + 5 7 
S 1036 c   2 1 
S 1042    1  
S 1062 m, c, z, d   1  
T 1063 m, x, c, z + + 6  
S 1069 x, c, d + + 6 3 
S 1077 m, c  + 1  
S 1082 d   1 1 
S 1098 m, x, c, d   1  
S 1118 m, x    1 
Y 1126     1 
S 1134    1 1 
S 1135    1 1 
S 1147 m, z   1 1 
S 1152    1  
S 1188   +   
S 1242 m   +  
 
Table 7: Table, summarizing the phosphorylation sites of PICH identified by mass spectrometry. 
Phosphorylation sites found within PICH-WT and PICH-TA after arresting cells in mitosis (nocodazole). 
Abbreviations: mouse (m), xenopus (x), C. elegans (c), drosophila (d) and zebrafish (z). 
Site Conservation 
(No. of unique peptides found; phos. / non-
phos.) 
PICH-WT PICH-WAB 
S 14 m 2/1 4/4 
S 441  1/2 1/4 
S 755 m, x, c 1/4 7/22 
S 759   5/24 
T 760 m, z, d  3/26 
T 763 m, x 2/3 4/25 
T 770 m, c, z  1/28 
S 774 m, x 1/2 2/4 
T 797 m 1/4 1/12 
S 807  2/3 3/11 
S 810   3/11 
T 813 m  1/13 
S 820 m, x, c 3/4 6/7 
S 829  1/6 3/10 
S 864 m, z 2/5 3/6 
S 905   2/15 
S 910 m, x 1/3 2/15 
S 913 x, c, z 1/3 3/14 
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S 946 x, c 1/3 3/6 
Y 949 m - 1/8 
S 971 c, z, 1/2 1/6 
S 980 m, d 1/2 3/4 
S 984   3/4 
T 997   2/23 
S 1000 m 4/7 5/20 
S 1004 m, z, d 4/7 6/19 
S 1028 m, x, c, z 3/3 9/10 
S 1036 c  1/18 
S 1042   1/17 
S 1049 m, x, z  3/15 
S 1069 x, c, d  1/3 
S 1082 d  2/4 
S 1092 m, x, c, z 1/4 2/6 
S 1117 m, x, c, z 2/1 5/1 
S 1118 m, x  1/5 
S 1134  1/4 2/12 
S 1135   1/13 
S 1139 x, c, z  1/13 
S 1147 m, z 1/3 1/11 
T 1172 m, c  1/15 
S 1173 m 2/6 3/13 
S 1181 m, c, z  1/15 
S 1188  3/5 8/8 
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5. DISCUSSION 
The DNA-dependent ATPase PICH was identified as a protein that dynamically associates with 
different parts of the mitotic chromosomes during the course of mitosis (Baumann et al., 2007). 
Furthermore, it was originally described as the “tension-sensor” of the SAC (Baumann et al., 
2007). However, this function of PICH as a component of the SAC has recently been attributed 
to an off-target effect of siRNA duplexes that do not only deplete PICH, but also Mad2 (Hübner 
et al., 2009). In the present study we have investigated the dynamic localization of PICH during 
the cell cycle in more detail. Furthermore, we have also re-examined the function of PICH and 
found it to be essential for the faithful resolution of chromatin bridges in late anaphase. 
 
5.1 Regulation of the subcellular localization of PICH 
In interphase PICH localizes to the cytoplasm and upon mitotic entry PICH gets relocalized to 
the centromere/KT region of chromosomes (Baumann et al., 2007). During anaphase it finally 
binds to ultra-fine DNA-bridges that connect separating sister chromatids and get resolved before 
mitotic exit. These striking changes in the subcellular localization of PICH are probably tightly 
regulated, but the underlying mechanisms have not previously been known. 
First, we investigated which domains of PICH are essential for chromosomal localization. We 
found that a mutant of PICH (PICH-NC) that lacks both the N- and C-terminal TPR domains 
localizes to chromosome arms. TPR domains are known to mediate protein-protein interactions. 
The fact that only the deletion of both TPR domains impairs PICH localization implies that 
either of the TPR domains is sufficient on its own. Moreover, this result also raises the question 
of whether the TPR domains of PICH mediate the interaction to a regulator of the chromosome 
arm localization of PICH and, if so, what the identity of this regulator is. 
Second, we tested the hypothesis that the ATPase activity of PICH might determine the 
localization of the protein. PICH has been predicted to be a DNA-dependent ATPase, which 
belongs to the family of SNF2/SWI helicases (Baumann et al., 2007). We initially proved this 
prediction by an in vitro ATPase assay. Indeed, we could demonstrate that PICH has ATPase 
activity in vitro that depends on the two classical ATPase-motifs Walker A and Walker B. 
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Interestingly, abolishing the ATPase activity of PICH in vivo recruits PICH all over the 
chromosome arms, arguing that the ATPase activity of PICH might be required for delocalizing 
PICH from the chromosome arms. Locking PICH in the chromosome arm-bound state by 
interference with its ATPase activity opens the question of whether PICH normally quickly turns 
over at chromosome arms in unperturbed cells and whether this turn-over has any functional 
significance. One could address the point whether turn-over occurs with photobleaching 
experiments. It is also possible that the inactivation of the ATPase activity might lock the protein 
in a functionally inactive state. The prolonged localization at chromosome arms could then 
simply be a result of the failure of PICH to fulfill its function at this location. Moreover, with 
regard to the role of the TPR domains of PICH in mediating chromosome arm localization, it 
would also be interesting to test whether the deletion of both TPR domains interferes with 
ATPase activity, and thereby leads to the localization of PICH to chromosome arms. 
Previously, Plk1 has been shown to regulate the chromosome arm localization of PICH during 
mitosis, as the knockdown or chemical inhibition of Plk1 recruits PICH from the centromere/KT 
to the chromosome arms or keeps it at chromosome arms (Baumann et al., 2007; Santamaria et 
al., 2007). In line with this, we asked whether Plk1 regulates the ATPase activity of PICH in vivo. 
We performed rescue experiments and found that PICH-TA localizes only to the centromere/KT 
and not to the chromosome arms, as expected for a direct relationship between PICH and Plk1. 
However, upon inhibition of Plk1 PICH-TA was still recruited all over chromosome arms. This 
demonstrates that Plk1 does not need to bind to PICH in order to control its localization, 
implying that Plk1 kinase activity regulates the chromosome arm localization of PICH indirectly, 
presumably by phosphorylation of an as yet unknown substrate at chromosome arms. 
It is known that during early mitosis, the kinase activity of Plk1 contributes to the removal of 
chromosome arm cohesin, an event which correlates with the delocalization of PICH (the 
prophase pathway) (Hauf et al., 2005; Sumara et al., 2002). But by rescue experiments we could 
rule out that the removal of chromosome arm cohesin by phosphorylation results in the 
delocalization of PICH from the arms. In line with this, also centromere/KT PICH is independent 
of centromere cohesin and cohesion, suggesting that the overall localization of PICH is 
independent of sister chromatid arm and centromere cohesin. However, the question to the 
substrate of Plk1 regulating PICH localization remains to be answered. As we have found that 
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the ATPase activity is required to remove PICH from chromosome arms, we further tested 
whether Plk1 regulates the ATPase activity of PICH in vivo and thereby influences the 
localization of PICH. However, the ATPase assays clearly show that PICH-TA is as active as 
wildtype PICH and the activity of wildtype PICH is unaffected even when Plk1 is chemically 
inhibited. Plk1, therefore, does not regulate the ATPase activity of PICH in vivo. 
We further show that the ATPase activity of PICH is not regulated during the cell-cycle. 
Therefore, we hypothesize that the function of PICH is regulated by its cell-cycle stage 
dependent localization rather than by the modulation of its ATPase activity. This is also in 
agreement with the reported localization of PICH in interphase when it localizes to the cytoplasm 
(Baumann et al., 2007). 
 
5.2 BEND3, a potential Plk1 substrate that regulates the localization of PICH 
and Plk1 
In order to identify proteins that regulate the localization of PICH we performed 
immunoprecipitation experiments, followed by mass spectrometry. Among the proteins that were 
found to interact with PICH, we identified the so far uncharacterized protein BEND3 that 
belongs to the family of BEN domain containing proteins. BEN domains have been predicted to 
mediate protein-DNA and protein-protein interactions during chromatin organization and 
transcription (Abhiman et al., 2008). In addition, BEND3 has recently been identified as 
chromatin associated (Ohta et al., 2010) and, indeed, we could confirm that BEND3-myc 
localizes to mitotic chromatin. BEND3 depletion results in mitotic catastrophe, which suggested 
that BEND3 is required for cellular viability. If BEND3 was indeed a regulator of PICH 
localization, one could make two predictions for the effect of BEND3 depletion on PICH 
localization. First, if BEND3 was the Plk1 substrate that has to be phosphorylated in order to 
delocalize PICH from chromosome arms, then the depletion of BEND3 should mimic the 
depletion or chemical inhibition of Plk1 and should therefore result in the chromosome arm 
localization of PICH. Alternatively, if BEND3 was only initially required to localize PICH to 
chromosome arms, its depletion should result in a delocalization of PICH. Interestingly, we 
found PICH to be completely delocalized in cells depleted of BEND3, suggesting that BEND3 
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might be required for the initial localization of PICH at chromatin. In addition, we could show 
that Plk1 is delocalized as well when BEND3 is depleted, although the structure of the KT and 
the mitotic spindle is not affected. Interestingly, cells that are depleted for PICH are positive for 
Plk1 at the KT and vice versa (Santamaria et al., 2007), demonstrating the independency of 
PICH and Plk1 at the KT. Furthermore, BEND3 interacts with and is a potential substrate of Plk1 
during mitosis, but this has to be tested further in the future. 
 
5.3 Functional characterization of PICH 
To circumvent the problem researchers faced in the past when depleting PICH by RNA 
interference we decided to use antibody microinjection to deplete PICH from living cells. To this 
end, we generated a monoclonal antibody against PICH. We show that neutralization of PICH 
does not affect SAC signaling, thereby confirming previous work which questioned the role of 
PICH in the SAC (Hübner et al., 2009). Surprisingly, we observed the occurrence of chromatin 
bridges and the formation of micronuclei as consequence of PICH depletion. Moreover, rescue 
experiments revealed that the ATPase activity of PICH is essential to prevent the formation of 
chromatin bridges. 
We have also explored the mechanisms by which PICH prevents the formation of chromatin 
bridges and micronuclei. PICH is predicted to be a helicase of the SNF2/SWI family that 
interacts with components of the BTR complex (Baumann et al., 2007; Hutchins et al., 2010). In 
line with this, the RecQ helicase BLM (that is mutated in Bloom syndrome) has been shown to 
be required for the faithful segregation of chromosomes and its localization during mitosis has 
been linked to unreplicated fragile site loci (Chan et al., 2007; Chan et al., 2009a; German, 1993; 
Naim and Rosselli, 2009a). 
Interestingly, we identified the protein Rif1 as a novel interaction partner of PICH. We also 
found that PICH regulates the localization of Rif1 to UFBs during mitosis. Rif1, initially 
characterized in humans to function downstream of ATM and 53BP1 in the S-phase checkpoint 
after DNA-damage (Silverman et al., 2004), has more recently been shown to contribute to cell 
survival after replication stress and to homology-directed DNA damage repair (Buonomo et al., 
2009). In addition, Rif1 interacts with and provides a DNA-binding interface for the BTR 
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complex to restart stalled replication forks and maintain normal replication (Xu et al., 2010). 
Unfortunately, to date it is unclear what the mitotic phenotype of Rif1 depletion is. Due to its 
connection to PICH it is possible that it is required for PICH localization or that its depletion 
could induce chromatin bridges. Therefore, it will be of great interest to analyze the link between 
PICH, Rif1 and BTR complex during mitotic progression. 
During interphase, both Rif1 and the BTR complex are recruited to sites of DNA damage 
(Silverman et al., 2004; Xu et al., 2010; Xu and Blackburn, 2004). However, PICH is not 
recruited to typical interphase DNA damage foci. Therefore, we speculate that PICH does not 
function in interphase, but plays a role in sister chromatid segregation during mitosis together 
with Rif1 and the BTR complex. 
We have shown that PICH-deficiency induced chromatin bridges arise from non-centromeric 
chromatin. This raises the intriguingly question why non-centromeric but not centromeric 
chromatin led to chromatin bridges in PICH depleted cells? One possible explanation could be 
that PICH is simply not required for the resolution of centromeric chromatin. However, a 
perhaps more likely explanation is that centromeric chromatin comprises a distinct structure of 
DNA that is different from non-centromeric chromatin. Centromeric UFBs have previously been 
shown to be very prominent in dividing cells and can furthermore be induced by the inhibition of 
a type 2 topoisomerase, which suggests that they are likely to represent fully replicated but still 
catenated DNA strands (Baumann et al., 2007; Chan et al., 2007). Therefore, when the SAC is 
satisfied and centromeric cohesion is released by the action of separase, a type 2 topoisomerase 
can gain access to the two entangled centromeric DNA strands and resolve them independently 
of PICH (Hauf et al., 2001; Wang et al., 2008). This potential mechanism is in striking contrast 
to the resolution of non-centromeric chromatin. In prometa- and metaphase, when chromosome 
arm cohesion is already released, non-centromeric UFBs are flanked by the Fanconi anemia 
proteins FANCD2 and FANCI (Chan et al., 2009a). Non-centromeric UFBs are likely, therefore, 
to represent loci of Holliday junctions (HJ) at stalled replication forks that need further resolution 
before the initiation of anaphase (Figure 46) (Chan et al., 2009a; Naim and Rosselli, 2009a). 
Thus, we would like to emphasize that non-centromeric UFBs are probably no conventional 
substrate for type 2 topoisomerases and that their resolution most likely requires a type 1 
topoisomerases (Figure 47), like TOP3A (for review see Wang, 2002). In line with this view, the 
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activity of type 1 topoisomerases has been implicated in the resolution of recombination 
intermediates before chromosome segregation and, more importantly, in a mechanistic way 
concluded to correlate with the degree of DNA negative supercoiling (Kirkegaard and Wang, 
1985; Wang, 2002; Zhu et al., 2001). Therefore, a helicase that pulls the branches of the 
replication fork is ultimately required to maintain the negative supercoiling and thereby keeping 
the type 1 topoisomerase active. In support of this notion, PICH associates with TOP3A and was 
shown to colocalize with members of the BTR complex to UFBs, as they emerged at fragile site 
loci (Chan et al., 2007; Chan et al., 2009a; Hutchins et al., 2010; Naim and Rosselli, 2009a). 
Thus, it is tempting to speculate that PICH functions in branch migration of stalled replication 
folks to constantly maintain the negative supercoiling for their resolution before the onset of 
anaphase. 
 
 
Figure 46: Proposed model for stalled replication fork recovery. When rescue mechanisms fail, daughter cells 
accumulate genomic anomalies like chromosome breakage or loss, represented by the appearance of micronuclei 
after cytokinesis. (a) An S/G2 nucleus stained by anti-FANCD2 (red) and anti-BLM (green) antibodies, showing 
partial colocalization of the foci formed by the two proteins (yellow dots). DNA (blue) was counterstained with 
DAPI. (b) A representative metaphase showing FANCD2 spots (red) on condensed chromosomes (blue). (c) A 
representative anaphase showing segregation of FANCD2 spots (red) and an ultrafine DNA bridge (white arrow) 
stained by BLM (green). Adapted from (Naim and Rosselli, 2009b). 
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Figure 47: Topoisomerases and HJ resolution. A) Subfamilies of DNA topoisomerases. B) Mode of action of a 
type IA topoisomerase. On transient breakage of a DNA strand (blue line), the 5′ end of the broken DNA strand is 
covalently attached to the active-site tyrosyl group (red circle) in the ‘lid’ of the enzyme, and the 3′ end is 
noncovalently bound to the ‘base’ of the enzyme. Lifting the lid away from the base opens a gate in the DNA for the 
passage of another strand (green circle). Once the second strand has entered the central cavity of the enzyme, it must 
exit the cavity, after the rejoining of the broken strand, without passing through the rejoined DNA strand. C) By 
successive passage of an AB strand through an ab strand, or vice versa, these intermolecular intertwines can be 
completely resolved by a type IA enzyme, but not by either a type IB or a type II enzyme. A-C) Adapted from 
(Wang, 2002). 
 
Although the different stages of mitosis have been intensively studied, DNA that connects the 
centromere/KTs of separating sister chromatids was only discovered through the localization of 
PICH, perhaps reflecting their inability to become visualized by conventional DNA dyes or 
fluorescently-tagged histones (Baumann et al., 2007). While PICH has become a robust marker 
for the detection of anaphase UFBs (Baumann et al., 2007; Chan et al., 2007; Chan et al., 2009a; 
Naim and Rosselli, 2009a), the question has remained of why anaphase UFBs have previously 
escaped detection. We tentatively provide two explanations, which are not mutually exclusive. 
The first and possibly the simplest explanation is that anaphase UFBs contain so little DNA that 
they simply cannot be visualized by conventional DNA dyes or fluorescently-tagged histones 
(Wang et al., 2008). Second, and more interesting from a mechanistic perspective, it has been 
shown in vitro that negative superhelical tension is released when DNA is wrapped around 
histones (Nakagawa et al., 2001; Pfaffle and Jackson, 1990). Assuming that PICH, together with 
a type 1 topoisomerase (Hutchins et al., 2010), removes negative superhelical tension, it would 
then be experimentally challenging to visualize anaphase UFBs with fluorescently-tagged 
histones when histone displacement correlates with the relaxation of negative superhelical 
tension. 
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5.4 Conclusions and Perspective 
The DNA-dependent ATPase PICH localizes to the centromere/KT region of prometa- and 
metaphase chromosomes (Baumann et al., 2007). Upon the onset of anaphase, PICH localizes to 
centromeric UFBs that increase in length before they diminish (Baumann et al., 2007; Wang et 
al., 2008). In the first part of this thesis, we have identified the TPR-domains and the ATPase 
activity of PICH as two key parameters regulating the correct localization of PICH. In addition, 
we have explored why depletion or chemical inhibition of Plk1 results in the relocalization of 
PICH to the chromosome arms during prometaphase (Baumann et al., 2007; Santamaria et al., 
2007), and asked through what mechanism Plk1 regulates the chromosome arm localization of 
PICH. Interestingly, the PICH-TA mutant (no Plk1 binding and thus no PICH phosphorylation 
on Plk1 sites) still localizes to chromosome arms when Plk1 is inhibited, revealing that Plk1 
must regulate PICH localization through phosphorylation of another, as yet unidentified substrate. 
In line with this conclusion, we have identified the previously uncharacterized protein BEND3 as 
a binding partner of PICH. BEND3 has two potential bindings sites for the Plk1-PBD that could 
in principle mediate binding to and phosphorylation by Plk1. Depletion of BEND3 results in a 
misalignment of chromosomes at the metaphase plate and leads to the selective loss of PICH and 
Plk1 from the centromere/KT, although the spindle apparatus and KTs are unaffected. 
Although we have identified mechanisms that regulate the dynamic localization of PICH, several 
questions remain unanswered. 
1. How do the TPR-domains of PICH influence its chromosome arm localization? 
2. Does PICH turn over at mitotic chromosomes? If so, is the ATPase activity of PICH 
 required? 
3. Is BEND3 the key Plk1 substrate that regulates the chromatin association of PICH? 
4. What is the mechanism that underlies the severe phenotype of BEND3 depletion? 
 
In the second part of this thesis, we have shown that PICH is important to prevent the formation 
of chromatin bridges during mitosis. Furthermore, we identified the new PICH-binding partner 
Rif1. Both PICH and Rif1 colocalize at centromeric UFBs and Rif1 has recently been shown to 
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provide a DNA-binding interface for the BTR complex (Xu et al., 2010). Interestingly, this 
complex is known to be required for the faithful segregation of chromosomes during mitosis 
(Chan et al., 2007). We could show that PICH mediates the localization of Rif1 to centromeric 
UFBs. Therefore, the delocalization of Rif1 could provide a plausible mechanism for how 
chromatin bridges arise in response to PICH depletion. Prompted by these findings, several 
interesting questions arise: 
1. Do the chromatin bridges that are induced by PICH depletion arise at specific loci of 
 DNA, e.g. at fragile site loci? 
2. How does PICH mediate the localization of Rif1 to centromeric UFBs? 
3. What is the mitotic phenotype of Rif1 depletion? 
4. Does PICH influence the holiday junction (HR)-resolving activity of the BTR complex? 
5. How do PICH, Rif1 and the BTR complex act together to prevent the formation of 
 chromatin bridges during mitosis? 
Hence, although PICH does not function as a central component of the spindle assembly 
checkpoint, this DNA-dependent ATPase clearly plays an important role in cell cycle 
progression.  While the present study substantially advances our understanding of PICH, it is 
clear that a full understanding of the function and regulation of this intriguing protein will 
require further study. 
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6. MATERIALS AND METHODS 
6.1 Antibody generation and antibodies used in this study 
The PICH monoclonal antibody (clone no.: 124-26-3, IgG1) was generated against a truncated 
version (aa79-aa752) of the human (NCBI Reference Sequence: NP_060139.2) recombinant His-
PICH protein expressed in E. coli. All mAbs were purified using HiTrap Protein G HP columns 
(GE Healthcare). 
The following antibodies were used in this study: mouse PICH mAB (Injection - 1mg/ml, IF - 
1mg/ml, WB - tissue culture supernatant in 1/10), rabbit PICH (Injection - 1mg/ml (Baumann et 
al., 2007)), mouse Mad2 mAB (Injection - 1mg/ml (Chan et al., 2009b)), mouse Myc mAB 
(Injection - 1mg/ml (Chan et al., 2009b)), mouse alpha-Tubulin (WB - 1/5000 (Sigma-Aldrich)), 
mouse Plk1 mAB (IF - 1mg/ml, WB - tissue culture supernatant in 1/10 (Hanisch et al., 2006)), 
human Crest autoimmune serum (IF - 1/2000 (Immunovision)), mouse GFP mAB (WB - tissue 
culture supernatant in 1/10), mouse CyclinB1 (WB - 1/1000 (Millipore)), rabbit IgG’s (Abcam, 
ab37415-5), mouse Lamin A+B2 mAB (IF - tissue culture supernatant in 1/10). For 
immunofluorescence analysis, primary antibodies were detected using Cy2-, Cy3-, or Cy5-
conjugated donkey anti–mouse, anti–rabbit, or anti–human IgGs (1/1000 (Dianova)). Secondary 
antibody used for western blot analysis was: goat anti-mouse (1/1000) obtained from Bio-Rad. 
 
6.2 Antibody microinjection 
Antibody microinjection was performed using the FemtoJet system equipped with Femtotips II 
purchased from Eppendorf (Hamburg, Germany) connected to an Axiovert S100 microscope 
from Zeiss (Jena, Germany). Antibody concentration was set to 1mg/ml in PBS including 
1.66mg/ml TexasRed dextran (Invitrogen). Positive injection was achieved with injection times 
varying between 0.2 – 0.4sec, capillary pressure of 30 – 40hPa and injection pressure between 
15-20hPa. Prior to the injection cells were seeded either on 35mm µ-Dishes with grid from Ibidi 
(Martinsried, Germany) for live-cell imaging or on coverslips for PTEMF fixation for indirect 
immunofluorescence. 
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6.3 Cloning procedures 
For cloning of His-hPICH (aa79-aa752) a previously published plasmid coding for human PICH 
was used (Baumann et al., 2007) together with DNA oligonucleotides 5’-
ACAGATGTGTGCAACTCTGGCTTG-3’ and 5’-AGGCTGAGGCTGTGGTTTATTCAA-3’ 
for in-frame cloning into a pET-28a(+) vector (Novagen). PICH-WT and PICH-TA (T1063 
mutated to alanine) tagged N-terminally to GFP were previously published (Baumann et al., 
2007). To generate PICH-WAB (mutated at K128 to alanine and E229 to glutamine) and PICH-
WAB-TA a mixture of DNA oligonucleotides was used: K128A: 5’- 
GATGATATGGGATTAGGGGCGACTGTTCAAATCATTGCT-3’, E229Q: 5’-
TATGTCATCCTCGATCAAGCACATAAAATAAAA-3’, T1063A: 5’- 
CAATTTGATGCTTCAGCTCCCAAAAATGACATC-3’ using the QuickChange Site-Directed 
Mutagenesis kit (Stratagene). To generate plasmids refractory to PICH siRNA duplexes a series 
of seven silent point mutations were introduced using the DNA oigonucleotide 5’- 
GTTTTTCTGCTTACCACTCAGGTGGGAGGAGTGGGATTGACATTAACTGCAGCA-3’ 
and it corresponding antisense. Underlined letters correspond to point mutations made. 
 
6.4 Cell culture and synchronization 
HeLa, U2OS, 293T and HeLa cells stably expressing H2B-GFP or H2B-mCherry were grown 
under standard conditions in DMEM (Invitrogen) supplemented with 10% FBS and penicillin 
and streptomycin (100 U/ml and 100 mg/ml, respectively) and cultured at 37°C, in a 5% CO2 
atmosphere. Cell cycle synchronizations were performed by a single thymidine (2 mM) block 
10-12 hrs post-transfection with siRNA duplexes. Nocodazole (100ng/ml), monastrol (150μM), 
puromycin (0.5μg/ml), and thymidine (2mM) were obtained from Sigma-Aldrich. MG132 
(10μM) was obtained from EMD. 
 
6.5 Cell extracts, immunoprecipitation and western blot analysis 
Preparation of lysates and Western blotting analysis were performed as described previously 
(Sillje et al., 2006) using Tris lysis buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 1% IGEPAL 
CA-630) containing 20mM NaF, 20mM beta-glycerophosphate, 0.3mM Na-Vanadate, 20µg/ml 
MATERIALS AND METHODS 
80 
RNase A, 20µg/ml DNase supplemented fresh with 1mM Pefabloc SC (Roth) and 1/100 
Phosphatase inhibitor cocktail 1+2 (Sigma-Aldrich). Immunoprecipitation against endogenouse 
PICH or overexpressed PICH was carried out using 0.5µg of corresponding antibody in addition 
to 20µL Affi-Prep protein A agarose beads (Bio-Rad) for 2 hours at 4°C followed by extensive 
washing with lysis buffer and PBS, supplemented to western blot analysis. Proteins were 
resolved by SDS-PAGE and transferred to Nitrocellulose or PVDF membranes (Millipore) and 
these were probed with primary antibodies overnight at 4°C. Membranes were washed with 0.5% 
Tween/PBS before incubation with secondary antibodies. Antibodies used are listed in the 
Appendix. 
 
6.6 Enzyme-coupled ATPase assay 
To analyze the ATPase activity of PICH a reaction-solution was prepared as follows: 25mM 
TEA pH 7.5, 13mM Mg-Acetate, 1.8mM DTT, 5mM ATP, 100µg/ml BSA, 3mM 
phosphoenolpyruvate, 20U/ml Pyruvate kinase, 20U/ml Lactic dehydrogenase purchased from 
Sigma-Aldrich. To measure the decrease of OD 340nm, following the conversion of NADH to 
NAD+, the starting OD at 340nm of 2.5 - 3.0 was set by addition of NADH (20mg/ml) using a 
Ultrospec 3100 pro (GE Healthcare) in a total reaction volume of 125µl. Individual treated PICH 
was added as immunoprecipitate, linked to protein A agarose (Bio-Rad), and analyzed at OD 
340nm in measurements at every 5 min in a total reaction time of 1 hour. To obtain optimal 
results, the reaction volume was mixed gently by pipetting up and down every 5 minutes. 
Graphical and statistical analysis was performed using SigmaPlot 11 (Systat Software Inc.). 
 
6.7 Flow cytometry 
Indicated cell lines were treated as mentioned, harvested by trypsinization and washed twice with 
10mL PBS. Cells were fixed by addition of -20°C 70% ethanol in cold PBS and stored at 4°C. 1 
hour prior to flow cytometry analysis cells were washed twice with ice-cold PBS and 
supplemented with 10 times the volume of the cell pellet of PBS plus 20mg/ml RNAse and 1/200 
propidium iodide (1mg/ml, purchased from Sigma-Aldrich). 
 
MATERIALS AND METHODS 
81 
6.8 Immunofluorescence microscopy 
Cells were grown on coverslips, fixed with PTEMF (immunostaining for kinetochore associated 
proteins) for 10 min at room temperature (Stucke et al., 2002) or -20°C methanol 
(immunostaining for phosphor-specific antibodies) for 10 min at -20°C, and incubated for 20 
min at room temperature in 3% BSA/PBS. Antibody incubations were carried out for 1 h at room 
temperature, followed by three washes in 0.5% TritonX-100/PBS. DNA was stained with 1 
μg/ml 4,6-diamidino-2-phenylindole (DAPI). Primary antibodies for immunostaining are listed 
in the Appendix. Primary antibodies were detected by Cy3-conjugated donkey antibodies 
(Dianova) and Alexa Fluor 647-conjugated goat antibodies (Invitrogen). Coverslips were 
mounted in phenylenediamine in 90% glycerol (v/v). Images were acquired using a DeltaVision 
Olympus IX71 microscope equipped with a 60x/1.42 oil objective. Collection and processing of 
acquired images was carried out using Softworx (Applied Precision, LLC). Samples were 
examined with optical sections acquired 0.4 μm apart in the z-axis, deconvolved for each focal 
plane and projected into a single plane image using the Softworx software (Applied Precision, 
LLC). Images were processed in Adobe Photoshop CS3 and figures were assembled using 
Adobe Illustrator CS4 (Adobe Systems). 
 
6.9 Transient plasmid and siRNA transfection 
Plasmid transfection was performed using TransIT-LT1 reagent (Mirus Bio Corporation) 
according to the manufacturer’s instructions. siRNA duplexes were transfected using 
Oligofectamine (Invitrogen) as described previously (Elbashir et al., 2001). All used siRNA 
duplex sequences can be found in the Appendix. All plasmid and siRNA transfections were 
performed for 48hrs to 72hrs with cells synchronized for the last 24hrs in the presence of 2mM 
thymidine. 
 
6.10 Time-laps microscopy 
HeLaS3 cells stably expressing histone 2B-GFP (Sillje et al., 2006) or histone 2B-mCherry 
(Steigemann et al., 2009) were seeded in eight-well chambers from Ibidi (Martinsried, Germany), 
treated as indicated and imaged using a Nikon ECLIPSE Ti microscope equipped with a 
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CoolLED pE-1 excitation system and a 20x/0.75 air Plan Apo objective (Nikon). Images were 
acquired at multiple positions every 3 minutes. For antibody injection, GFP fluorescence and 
DIC images were acquired at each time point with 20msec and 2msec exposure times, 
respectively. TexasRed fluorescence was imaged every 5 time points with a 40msec exposure. 
For gene knockdown and rescue experiments, histone 2B-mCherry fluorescence was acquired at 
every time point with a 20msec exposure time. DIC images were collected as described above. 
To collect and process data MetaMorph 7.7 software (MDS Analytical Technologies) in 
combination with SigmaPlot 11 (Systat Software Inc.) was used. 
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7. APPENDIX 
7.1 List of generated plasmids 
name gene insert tag species vector comment 
MK01 PICH PICH (ATB binding mutant, GAT) N-Gal4-AD human pAcT2 Yeast Two Hybrid 
MK02 PICH PICH (ATB binding mutant, GAT) N-Gal4-BD human pFBT9 Yeast Two Hybrid 
MK03 PICH PICH (1-693) N-Gal4-AD human pAcT2 Yeast Two Hybrid 
MK04 PICH PICH (1-693) N-Gal4-BD human pFBT9 Yeast Two Hybrid 
MK05 PICH PICH (628-1250) N-Gal4-AD human pAcT2 Yeast Two Hybrid 
MK06 PICH PICH (628-1250) N-Gal4-BD human pFBT9 Yeast Two Hybrid 
MK07 PICH PICH (ATB binding mutant, GAT) N-his human pvl1393 insect expression 
MK08 PICH PICH (1-892) N-Gal4-BD human pFBT9 Yeast Two Hybrid 
MK09 PICH PICH (628-1250; T1063A mutant N-Gal4-BD human pFBT9 Yeast Two Hybrid 
MK10 PICH PICH 1-580 flag human pcDNA3.1-flag Mam. expression 
MK11 PICH PICH 1-693 flag human pcDNA3.1-flag Mam. expression 
MK12 PICH PICH 1-892 flag human pcDNA3.1-flag Mam. expression 
MK13 PICH PICH PFD  human pFBT9 Y2H 
MK14 PICH PICH PFD-892  human pFBT9 Y2H 
MK15 PICH PICH 689-1088  human pFBT9 Y2H 
MK16 PICH PICH 1-1088 flag human pcDNA3.1-flag Mam. expression 
MK17 PICH PICH T1063E GFP human peGFPC2 Mam. expression 
MK18 PICH PICH T235A GFP human peGFPC2 Mam. expression 
MK19 PICH PICH S338A GFP human peGFPC2 Mam. expression 
MK20 PICH PICH T235A + S338A GFP human peGFPC2 Mam. expression 
MK21 PICH PICH T303A GFP human peGFPC2 Mam. expression 
MK22 PICH PICH T609A GFP human peGFPC2 Mam. expression 
MK23 PICH PICH S459A GFP human peGFPC2 Mam. expression 
MK24 PICH PICH T303E GFP human peGFPC2 Mam. expression 
MK25 PP2A PP2A catalytic subunit GFP human EX-C0306-M29 Mam. expression 
MK26 PICH PICH T303A flag human pcDNA3.1-flag Mam. expression 
MK27 PICH PICH S459A flag human pcDNA3.1-flag Mam. expression 
MK28 Sgo1 Sgo1 1-176 flag human pcDNA3.1-flag Mam. expression 
MK29 PICH PICH S790A GFP human peGFPC2 Mam. expression 
MK30 PICH PICH S774A GFP human peGFPC2 Mam. expression 
MK31 PICH PICH S945A GFP human peGFPC2 Mam. expression 
MK32 PICH PICH S945A + T1063A GFP human peGFPC2 Mam. expression 
MK33 Sgo2 Sgo2 wt (resistent to oligo 3 from YenT. et al) rfp human pcS2 Mam. expression 
O.Stemmann 
MK34 Sgo2 Sgo2 Mad2 deficient binding, KLMR 150-153 to 
AAAA 
rfp human pcS2 Mam. expression, gift from 
O.Stemmann 
MK35 Sgo2 Sgo2 PP2A deficient binding, N58 to I58 rfp human pcS2 Mam. expression, gift from 
O.Stemmann 
MK36 PICH PICH T454A GFP human peGFPC2 Mam. expression 
MK37 PICH PICH S683A GFP human peGFPC2 Mam. expression 
MK38 PICH PICH 1-752, n-term his his human pET28 bacterial expression 
MK39 PICH PICH 1-571, n-term his his human pET28 bacterial expression 
MK40 PICH PICH 1-454, n-term his his human pET28 bacterial expression 
MK41 PICH PICH 1-421, n-term his his human pET28 bacterial expression 
MK42 PICH PICH 1-632, n-term his his human pET28 bacterial expression 
MK43 PICH PICH 79-752, n-term his his human pET28 bacterial expression 
MK44 PICH PICH 79-632, n-term his his human pET28 bacterial expression 
MK45 PICH PICH 79-571, n-term his his human pET28 bacterial expression 
MK46 PICH PICH 79-454, n-term his his human pET28 bacterial expression 
MK47 PICH PICH 79-421, n-term his his human pET28 bacterial expression 
MK48 PICH PICH 1-715aa His (N) human pET28b Bacterial expression 
MK49 PICH PICH S459A + S790A GFP human pEGFP-C2 Mam. expression 
MK50 PICH PICH T797A GFP human pEGFP-C2 Mam. expression 
MK51 PICH PICH S864A GFP human pEGFP-C2 Mam. expression 
MK52 PICH PICH T1063D GFP human peGFPC2 Mam. expression 
MK53 PICH PICH 459E+790E GFP human peGFPC2 Mam. expression 
MK54 PICH PICH S143A GFP human peGFPC2 Mam. expression 
MK55 PICH PICH T185A GFP human peGFPC2 Mam. expression 
MK56 PICH PICH T509A GFP human peGFPC2 Mam. expression 
MK57 PICH PICH 530A GFP human peGFPC2 Mam. expression 
MK58 PICH PICH S557A GFP human peGFPC2 Mam. expression 
MK59 PICH PICH minus N-TRP GFP human peGFPC2 Mam. expression 
MK60 PICH PICH minus C-TRP GFP human peGFPC2 Mam. expression 
MK61 PICH PICH minus NC-TPR GFP human peGFPC2 Mam. expression 
MK62 Wapl wt Myc human pcDNA3.1-myc Mam. expression 
MK63 PICH PICH A28W GFP human peGFPC2 Mam. expression 
MK64 PICH PICH G1207W GFP human peGFPC2 Mam. expression 
MK65 PICH PICH A28+G1207W GFP human peGFPC2 Mam. expression 
MK66 PPP1gama wt Myc human pcDNA3.1-myc Mam. expression 
MK67 PICH PICH T1063A Flag human pcDNA3.1-flag Mam. expression 
MK68 PICH PICH S807A GFP human pEGFP-C2 Mam. expression 
MK69 ILF3 wt Flag human pcDNA3.1-flag Mam. expression 
MK70 PICH PICH G1207W Flag human pcDNA3.1-flag Mam. expression 
MK71 PICH PICH A28W+G1207W Flag human pcDNA3.1-flag Mam. expression 
MK72 PICH wt Flag human pcDNA3.1-flag Mam. expression 
MK73 PICH wt Myc human pcDNA3.1-myc Mam. expression 
MK74 PICH 774A,807A,810A,813A,864A GFP human peGFPC2 Mam. expression 
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MK75 PICH 774A,807A,810A,813A,864A, 995A GFP human peGFPC2 Mam. expression 
MK76 PICH PICH minus N-TPR Flag human pcDNA3.1-flag Mam. expression 
MK77 PICH PICH minus N-TPR Myc human pcDNA3.1-myc Mam. expression 
MK78 PICH PICH minus C-TPR Flag human pcDNA3.1-flag Mam. expression 
MK79 PICH PICH minus C-TPR Myc human pcDNA3.1-myc Mam. expression 
MK80 PICH PICH minus N+C-TPR Flag human pcDNA3.1-flag Mam. expression 
MK81 PICH PICH minus N+C-TPR Myc human pcDNA3.1-myc Mam. expression 
MK82 PICH PICH A28W+F44A Flag human pcDNA3.1-flag Mam. expression 
MK83 PICH PICH GAT+DQAH GFP human peGFPC2 Mam. expression 
MK84 PICH 774A,807A,810A,813A,864A, 995A GFP human peGFPC2 Mam. expression 
MK85 PICH PICH S1028E GFP human peGFPC2 Mam. expression 
MK86 PICH 774A,807A,810A,813A,864A, 995A, 980, 1098 GFP human peGFPC2 Mam. expression 
MK87 PICH PICH 820A+1028A GFP human peGFPC2 Mam. expression 
MK88 PICH PICH minus N-TPR (oligo 1 res.) GFP human peGFPC2 Mam. expression 
MK89 PICH PICH minus C-TPR (oligo 1 res.) GFP human peGFPC2 Mam. expression 
MK90 PICH PICH minus N+C-TPR (oligo 1 res.) GFP human peGFPC2 Mam. expression 
MK91 SA2 SA2 12xA GFP human peGFPC2 Mam. Expression, gift from 
O. Stemmann 
MK92 PICH 11xA (Cdk1 sites) GFP human peGFPC2 Mam. expression 
MK93 PICH PICH GAT+DQAH GFP human peGFPC2 Mam. expression 
MK94 PICH Wt (oligo3 res.) GFP human peGFPC2 Mam. expression 
MK95 PICH T1063A (oligo3 res.) GFP human peGFPC2 Mam. expression 
MK96 PICH GAT+DQAH  (oligo3 res.) GFP human peGFPC2 Mam. expression 
MK97 PICH T1063A + GAT+DQAH (oligo3 res.) GFP human peGFPC2 Mam. expression 
MK98 PICH 11xA (Cdk1 sites)  (oligo3 res.) GFP human peGFPC2 Mam. expression 
MK99 BEND3 wt Myc human pcDNA3.1-myc Mam. expression 
MK100 SA2 SA2-12xA MYC human pcDNA3.1-myc Mam. expression 
 
7.2 List of DNA oligonucleotides 
DNA Oligo no.: Used for Comment Sequence 
M3967 cloning cloning-N-TPR Domain (XmaI) for pACT2 GCG CCCGGG C atggaggcatcccgaaggttt 
M3968 cloning cloning-C-TPR Domain (XmaI)  for pACT2 GCG CCCGGG C gctacaaatgactatgagactcttg 
M3969 cloning cloning-Pich Family Domain (XmaI)  for pACT2 GCG CCCGGG C tttacaatcgaggatcttcagaact 
M3970 cloning cloning-N-TPR Domain + stop codon (XhoI)  for pACT2 GCG CTCGAG TTA GATTCTGCTCAGCACTTTTTCATTG 
M3971 cloning cloning-C-TPR Domain + stop codon (XhoI)  for pACT2 GCG CTCGAG TCAATTGTTATTAAGTTGCTTATACAAAC 
M3972 cloning cloning-Pich Family Domain + stop codon (XhoI)  for 
pACT2 
GCG CTCGAG TTA TTCTTCTACCACATCAAGCTCTTC 
M3973 cloning cloning-HELICc Domain + stop codon (XhoI)  for 
pACT2 
GCG CTCGAG TTA CACAACATTCTCTTTTTGTCCAATTC 
M3974 cloning cloning-N-TPR Domain (SmaI) for pFBT9 GCG CCCGGG C atggaggcatcccgaaggttt 
M3975 cloning cloning-C-TPR Domain (SmaI) for pFBT9 GCG CCCGGG C gctacaaatgactatgagactcttg 
M3976 cloning cloning-Pich Family Domain (SmaI) for pFBT9 GCG CCCGGG C tttacaatcgaggatcttcagaact 
M3977 cloning cloning-N-TPR Domain + stop codon (SalI) for pFBT9 GCG GTCGAC TTA GATTCTGCTCAGCACTTTTTCATTG 
M3978 cloning cloning-C-TPR Domain + stop codon (SalI) for pFBT9 GCG GTCGAC TCA ATTGTTATTAAGTTGCTTATACAAAC 
M3979 cloning cloning-Pich Family Domain + stop codon (SalI) for 
pFBT9 
GCG GTCGAC TTA TTCTTCTACCACATCAAGCTCTTC 
M3980 cloning cloning-HELICc Domain + stop codon (SalI) for pFBT9 GCG GTCGAC TTA CACAACATTCTCTTTTTGTCCAATTC 
M4028 cloning PICH (689 - C-term.) XmaI for pACT2 gcgcccggggcgatgtggtagaagaatctcactata 
M4029 cloning PICH (883 – C-term.) XmaI for pACT2 gcgcccgggccaactaaaggatgatgagattttacg 
M4030 cloning PICH (1080 – C-term.) XmaI for pACT2 gcgcccgggccccagtagtgtaaataagtctatga 
M4031 cloning PICH (N-term. - 892) XhoI for pACT2 gcgctcgagttaacgtaaaatctcatcatcctttagttg 
M4032 cloning PICH (N-term. - 1088) XhoI for pACT2 gcgctcgagttagttcatagacttatttacactactggg 
M4033 cloning PICH (N-term. - 892) SalI for pFBT9 gcggtcgacttaacgtaaaatctcatcatcctttagttg 
M4034 cloning PICH (N-term. - 1088) SalI for pFBT9 gcggtcgacttagttcatagacttatttacactactggg 
M4291 Site-Direct Mut PICH T235A f1 GCACATAAAATAAAAGCCTCATCTACTAAGT 
M4292 Site-Direct Mut PICH T235A r1 ACTTAGTAGATGAGGCTTTTATTTTATGTGC 
M4293 Site-Direct Mut PICH S338A f1 GTACAGAAGAAAAAGGCAAGCAACCCAGAGG 
M4294 Site-Direct Mut PICH S338A r1 CCTCTGGGTTGCTTGCCTTTTTCTTCTGTAC 
M4328 cloning PICH Xho1 for peGFP-C1 gcgCTCGAGGCatggaggcatcccgaaggttt 
M4329 cloning PICH (1-892) Xma1 for peGFP-C1 gcg CCCGGG A CGTAAAATCTCATCATCCTTTAGTTG 
M4330 cloning PICH (1-1088) Xma1 for peGFP-C1 gcgCCCGGGGTTCATAGACTTATTTACACTACTGGG 
M4340 Site-Direct Mut PICH-T1063E-f1 AATTTGATGCTTCAGAGCCCAAAAATGACAT 
M4341 Site-Direct Mut PICH-T1063E-r1 ATGTCATTTTTGGGCTCTGAAGCATCAAATT 
M4342 cloning FBX22-f1 KpnI for pcDNA3.1 C1 GCG GGTACC T ATGGAGCCGGTAGGCTGCTGCGG 
M4343 cloning FBX22-r1 XhoI for pcDNA3.1 C1 GCG CTCGAG TTATTTAGATGACCCCAGATGTATG 
M4344 cloning FBX22-f2 XhoI for peGFP C1 GCG CTCGAG CC ATGGAGCCGGTAGGCTGCTGCGG 
M4345 cloning FBX22-r2 SmaI/XmaI for peGFP C1 GCG CCCGGG TTATTTAGATGACCCCAGATGTATG 
M4346 Nested PCR nesFBX22-f1 GTTCCTCCGAGCCGCCGTAGGACT 
M4347 Nested PCR nesFBX22-r1 CAGAACCCAAAAGTTACATATTATG 
M4379f Site-Direct Mut PICH-T303A f GAGAGAAGGATGCTGCCCCAGGAGAAAAAGCC 
M4379r Site-Direct Mut PICH-T303A r GGCTTTTTCTCCTGGGGCAGCATCCTTCTCTC 
M4380 Site-Direct Mut PICH-T303E f GAGAGAAGGATGCTGAGCCAGGAGAAAAAGCC 
M4381 Site-Direct Mut PICH-T303E r GGCTTTTTCTCCTGGCTCAGCATCCTTCTCTC 
M4391 Site-Direct Mut PICH S459E f1 acattgatggaagaagagggaaaaatgatattc 
M4392 Site-Direct Mut PICH S459E r1 GAATATCATTTTTCCCTCTTCTTCCATCAATGT 
M4393 Site-Direct Mut PICH T609E f1 cattaataagacaaactgagggtgaaaaaaagaac 
M4394 Site-Direct Mut PICH T609E r1 GTTCTTTTTTTCACCCTCAGTTTGTCTTATTAATG 
M4400 cloning PP2AC-f1 pcDNA3.1-flag - Kpn1 GCGGGTACCGATGGACGAGAAGGTGTTCACCAAG 
M4401 cloning PP2AC-r1 pcDNA3.1-flag - Apa1 GCGGGGCCCTTACAGGAAGTAGTCTGGGGTACG 
M4402 Site-Direct Mut PP2AC PD -f1  D88A ATGGGAGATTATGTTGCCAGAGGATATTATTCA 
M4403 Site-Direct Mut PP2AC PD -r1  D88A TGAATAATATCCTCTGGCAACATAATCTCCCAT 
M4404 cloning Sgo1-f1 Kpn1 for pcDNA3.1 flag GCGGGTACCTATGGCCAAGGAAAGATGCCTGAAA 
M4405 cloning Sgo1-r1  Xho1 GCGCTCGAGTCATTGTATTTGTTTCATACTTTT 
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M4406 cloning Sgo1-r2  aa1-176 Xho1+Stopcodon GCGCTCGAGTCAACCTGAATCAAAATCAACTCCCAG 
M4407 cloning Sgo1- for-nested Primer GGAGGAAGATAGCTGTTGCAGAAG 
M4408 cloning Sgo1- rev-nested Primer GCAACAGAAAGAGGTGTAGATTG 
M4436 Site-Direct Mut PICH T740A f TTTCCTTCTTCAGCAAAGAAGAAATGCCCT 
M4437 Site-Direct Mut PICH T740A r AGGGCATTTCTTCTTTGCTGAAGAAGGAAA 
M4438 Site-Direct Mut PICH S774A f AGTTCCAAAATGGCAGCCGTAGTCATTGATGAT 
M4439 Site-Direct Mut PICH S774A r ATCATCAATGACTACGGCTGCCATTTTGGAACT 
M4440 Site-Direct Mut PICH S790A f GAGAAACAAGATCTCGCCAGTATAAAGGTGAAT 
M4441 Site-Direct Mut PICH S790A r ATTCACCTTTATACTGGCGAGATCTTGTTTCTC 
M4442 Site-Direct Mut PICH S14A f GAAGCCGAGGCCTTGGCCCCAGAGCAGGCTGCT 
M4443 Site-Direct Mut PICH S14A r AGCAGCCTGCTCTGGGGCCAAGGCCTCGGCTTC 
M4454 Site-Direct Mut PICH S945A f GAGGAACCTTCAGCAGCTTCACCACAGTATGCA 
M4455 Site-Direct Mut PICH S945A r TGCATACTGTGGTGAAGCTGCTGAAGGTTCCTC 
M4509 Site-Direct Mut Plk1 K200A f TTTGGACTGGCAACC GCA GTCGAATATGACGGG 
M4510 Site-Direct Mut Plk1 K200A r CCCGTCATATTCGACTGCGGTTGCCAGTCCAAA 
M4511 Site-Direct Mut Plk1 K265A f TACCTCCGGATCAAG GCG AATGAATACAGTATT 
M4512 Site-Direct Mut Plk1 K265A r AATACTGTATTCATTCGCCTTGATCCGGAGGTA 
M4513 Site-Direct Mut Plk1 K358A f GAGCGTCCCCGGGAA GCA GAAGAACCAGTGGTT 
M4514 Site-Direct Mut Plk1 K358A r AACCACTGGTTCTTCTGCTTCCCGGGGACGCTC 
M4558 Site-Direct Mut PICH S790E f GAGAAACAAGATCTC GAA AGTATAAAGGTGAAT 
M4559 Site-Direct Mut PICH S790E r ATTCACCTTTATACTTTCGAGATCTTGTTTCTC 
M4560 cloning PICH 428 r (XhoI) GCG CTCGAG TTA CCCAAGATTTAGCAAACAACAAG 
M4561 cloning PICH 99 r (XhoI) GCG CTCGAG TTA GTGCTCAAAGAGTTGGTTGTGCAG 
M4667 Nested PCR PP2A A alpha f nes CGTTTCAGCACAGCGCTGGCCGCAG 
M4668 Nested PCR PP2A A alpha r nes GAGGGACTTGTGGGGGTTGGAGGG 
M4669 cloning PP2A A alpha f  for pcDNA-flag kpn1 GCG GGTACC CC ATGGCGGCGGCCGACGGCGACGAC 
M4670 cloning PP2A A alpha r for pcDNA-flag xho1 GCG CTCGAG TTA TCAGGCGAGAGACAGAACAGTCAG 
M4671 Nested PCR PP2A A beta f nes GGGGCCTGGGCGCGGGGCGGGAG 
M4672 Nested PCR PP2A A beta r nes GACTAGAAATTTGTGACAAGAATC 
M4673 cloning PP2A A beta f for pcDNA-flag kpn1 GCG GGTACC CC ATGGCGGGCGCATCAGAGCTCGGG 
M4674 cloning PP2A A beta r for pcDNA-flag xho1 GCG CTCGAG TTA TGCCAATGCAAGAACACTTATAG 
M4675 Nested PCR PP2A C alpha f nes GTGCGGGCGGCGGCGCGGGAGCAGC 
M4676 Nested PCR PP2A C alpha r nes CCATTAGGTCGATATATGGTTC 
M4685 cloning PICH aa1 for (Nde1) GCG CATATG ATGGAGGCATCCCGAAGGTTTCC 
M4686 cloning PICH aa79 for (Nde1) GCG CATATG ACAGATGTGTGCAACTCTGGCTTG 
M4687 cloning PICH aa752 rev (Xho1) GCG CTCGAG TTA AGGCTGAGGCTGTGGTTTATTCAA 
M4688 cloning PICH aa715 rev (Xho1) GCG CTCGAG TTA TTTATTTTGAGACTCGAATTCAAC 
M4689 cloning PICH aa632 rev (Xho1) GCG CTCGAG TTA ATCCTCGATTGTAAAGAGCTCTC 
M4690 cloning PICH aa571 rev (Xho1) GCG CTCGAG TTA AACCACAACATTCTCTTTTTGTC 
M4691 cloning PICH aa454 rev (Xho1) GCG CTCGAG TTA TGTGTCATCAGTTACTTGATCAAT 
M4692 cloning PICH aa421 rev (Xho1) GCG CTCGAG TTA AGCCCGTGCAGACAGCAGCCTAG 
M4721 cloning PICHr for pcDNA3.1 flag + NLS + Stop (Xho1) CTCGAG TCACACCTTGCGCTTCTTCTTCGGCGGCC 
CATTGTTATTAAGTTGCTTATAC 
M4724 cloning Sgo2-f1 for pcDNA3.1 flag GCG GGTACC T ATGGAGTGCCCAGTGATGGAAAC 
M4725 cloning Sgo2-r1 for pcDNA3.1 flag GCG CTCGAG TCATCTTCTCATCTTGTCTCTGAG 
M4726 Nested PCR nesSgo2-f CTGAGCTGGGTGGGGGTGCCCC 
M4727 Nested PCR nesSgo2-r GATTCCTTATGCTTTGAAAATTC 
M4863 Site-Direct Mut PICH T454A for CAAGTAACTGATGAC GCA TTGATGGAAGAATCT 
M4864 Site-Direct Mut PICH S683A for GTACACATGTGATCTG GCT GTTAAAGAAGAGCTT 
M4902 Site-Direct Mut PICH T454A rev AGATTCTTCCATCAATGCGTCATCAGTTACTTG 
M4903 Site-Direct Mut PICH S683A rev AAGCTCTTCT TTAACAGCCA GATCACATGT GTAC 
M4936 sequencing pp2aaa599down CGTCAAGAGTGAGATCATCCC 
M4937 sequencing pp2aaa346up CAGAGGGCGAGTGCTCGTGTG 
M4951 sequencing Sgo2 550down CATTACCTGATATTCCCTCTTC 
M4952 sequencing Sgo2 1102down CTGCTAGTGAAGTCAGCAAAATTG 
M4953 sequencing Sgo2 1648down CAAACCAAAAGGATAAAGTAAC 
M4954 sequencing Sgo2 2200down GTATAGAATACACAGTTAAAAG 
M4955 sequencing Sgo2 2752down CTGAAATGAACCAGATATATG 
M4956 sequencing Sgo2 3300down GACAGCGTTCAGGGAAAGTC 
M5041 sequencing Sgo2 680up CTCTGGGAGGTACATCAACTATAG 
M5119 Site-Direct Mut PICH T1063D f CAATTTGATGCTTCAGACCCCAAAAATGACATC 
M5120 Site-Direct Mut PICH T1063D r GATGTCATTTTTGGGGTCTGAAGCATCAAATTG 
M5121 Site-Direct Mut PICH T797A f ATAAAGGTGAATGTTGCCACCTTGCAAGATGGT 
M5122 Site-Direct Mut PICH T797A r ACCATCTTGCAAGGTGGCAACATTCACCTTTAT 
M5123 Site-Direct Mut PICH S864A f GAGGATCCTCTGGAAGCTTTTAATTATGTACTT 
M5124 Site-Direct Mut PICH S864A r AAGTACATAATTAAAAGCTTCCAGAGGATCCTC 
M5200 cloning PICH aa1 for (Not1) GCG GCGGCCGC A ATGGAGGCATCCCGAAGGTTTCC 
M5201 cloning PICH aa79 for (Not1) GCG GCGGCCGG A ACAGATGTGTGCAACTCT 
GGCTTG 
M5218 Site-Direct Mut PICH T329A f TTTCTCAGGAGGGCTAAAGAAGACGTA 
M5219 Site-Direct Mut PICH T329A r TACGTCTTCTTTAGCCCTCCTGAGAAA 
M5220 Site-Direct Mut PICH S652A f GCTCAGAGGAAAGCTGATATAAAACTA 
M5221 Site-Direct Mut PICH S652A r TAGTTTTATATCAGCTTTCCTCTGAGC 
M5222 Site-Direct Mut PICH S1092A f AACTCTAGAAGAGCTCTGGCTTCTAGG 
M5223 Site-Direct Mut PICH S1092A r CCTAGAAGCCAGAGCTCTTCTAGAGTT 
M5224 Site-Direct Mut PICH S1098A f GCTTCTAGGAGGGCTCTTATTAATATG 
M5225 Site-Direct Mut PICH S1098A r CATATTAATAAGAGCCCTCCTAGAAGC 
M5226 Site-Direct Mut PICH S143A f ATGTTTGATGCAGCACTTGTGAATCAT 
M5227 Site-Direct Mut PICH S143A r ATGATTCACAAGTGCTGCATCAAACAT 
M5228 Site-Direct Mut PICH T185A f AAGGATGAACGGGCCAGAAACCTCAAT 
M5229 Site-Direct Mut PICH T185A r ATTGAGGTTTCTGGCCCGTTCATCCTT 
M5230 Site-Direct Mut PICH T509A f CGAATCGATGGGGCAGTTACTCATCTT 
M5231 Site-Direct Mut PICH T509A r AAGATGAGTAACTGCCCCATCGATTCG 
M5232 Site-Direct Mut PICH S530A f AATAAAGATTACGCTGTTTTTCTGCTT 
M5233 Site-Direct Mut PICH S530A r AAGCAGAAAAACAGCGTAATCTTTATT 
M5234 Site-Direct Mut PICH S557A f ATTTTTGACCCTGCCTGGAATCCTGCA 
M5235 Site-Direct Mut PICH S557A r TGCAGGATTCCAGGCAGGGTCAAAAAT 
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M5270 cloning PICH 95 (Xho1) for peGFP down gcgCTCGAG CG CAACTCTTTGAGCACCAGAAGG 
M5271 cloning PICH 1195 (Xma1) for peGFP up gcgCCCGGG TTA CTCTGCCGCCTTATCCTGGGG 
M5299 Site-Direct Mut PICH S1134-5A f GAAGGGGTGGAGGAAGCCGCCGGCGAAGCCTCCAAG 
M5300 Site-Direct Mut PICH S1134-5A r CTTGGAGGCTTCGCCGGCGGCTTCCTCCACCCCTTC 
M5301 Site-Direct Mut PICH S1036A f GAAGATGAAGATGAT GCT  TTTAAAGATACCTCA 
M5302 Site-Direct Mut PICH S1036A r TGAGGTATCTTTAAAAGCATCATCTTCATCTTC 
M5330 Site-Direct Mut CyclinB1 R42A f CCCGGACTGAGGCCAGCAACAGCTCTTGGGGAC 
M5331 Site-Direct Mut CyclinB1 R42A r GTCCCCAAGAGCTGTTGCTGGCCTCAGTCCGGG 
M5342 cloning Wapl Kpn1 down - for pcDNA3.1 myc/flag gcgGGTACCCATGACATCCAGATTTGGGAAAACA 
M5343 cloning Wapl Xho1 up - for pcDNA3.1 myc/flag gcgCTCGAG CTAGCAATGTTCCAAATATTCAAT 
M5351 cloning SA2 Kpn1 down - for pcDNA3.1 myc/flag gcgGGTACCCatgatagcagctccagaaatacc 
M5352 cloning SA2 Xho1 up - for pcDNA3.1 myc/flag gcgCTCGAGTTAAAACATTGACACTCCAAGAAC 
M5395 Site-Direct Mut PICH A28W f AGATATGTGAAAGAG TGG AAAGAAGCAACTAAG 
M5396 Site-Direct Mut PICH A28W r CTTAGTTGCTTCTTTCCACTCTTTCACATATCT 
M5397 Site-Direct Mut PICH G1207W f ACTCTTGTAAAGCGT TGG AAAGAACTAAAAGAG 
M5398 Site-Direct Mut PICH G1207W r CTCTTTTAGTTCTTTCCAACGCTTTACAAGAGT 
M5417 cloning PP1 gamma Kpn1 down- for pcDNA31. myc/flag gcgGGTACCC ATGGCGGATTTAGATAAACTCA 
M5418 cloning PP1 gamma Xho1 up- for pcDNA31. myc/flag gcgCTCGAG CTATTTCTTTGCTTGCTTTGTG 
M5431 cloning PCNA BamH1 down for pcDNA3.1 myc flag gcgGGATCCATGTTCGAGGCGCGCCTGGTCCAG 
M5432 cloning PCNA Xho1 up for pcDNA3.1 myc flag gcgCTCGAGCTAAGATCCTTCTTCATCCTCGATC 
M5433 cloning FEN1 Kpn1 down for pcDNA3.1 myc flag gcgGGTACC C ATGGGAATTCAAGGCCTGGCCAAAC 
M5434 cloning FEN1 Xho1 up for pcDNA3.1 myc flag gcgCTCGAGTTATTTTCCCCTTTTAAACTTCCC 
M5441 Site-Direct Mut PICH S807 f GGTAAAGGTACAGGTGCTGCTGACTCTATAGCT 
M5442 Site-Direct Mut PICH S807 r AGCTATAGAGTCAGCAGCACCTGTACCTTTACC 
M5443 Site-Direct Mut PICH S984 f AATAGCTTGTGTGGCGCTGCACCTAATTCCAGA 
M5444 Site-Direct Mut PICH S984 r TCTGGAATTAGGTGCAGCGCCACACAAGCTATT 
M5445 Site-Direct Mut PICH S980 f GTTGAGAAAGAAAATGCCTTGTGTGGCTCTGCA 
M5446 Site-Direct Mut PICH S980 r TGCAGAGCCACACAAGGCATTTTCTTTCTCAAC 
M5447 Site-Direct Mut PICH S807 + S810 + T813 f GGTACAGGTGCTGCTGACGCTATAGCTGCTTTAC 
CAAAGGGG 
M5448 Site-Direct Mut PICH S807 + S810 + T813 r CCCCTTTGGTAAAGCAGCTATAGCGTCAGCAGC 
ACCTGTACC 
M5449 cloning ILF3 nested f CACCAAGGAACTCTATCACAATTTG 
M5450 cloning ILF3 nested r GTTAACTGTGATGCATAAAACTCGATC 
M5451 cloning ILF3 Kpn-f gcgGGTACCCATGCGTCCAATGCGAATTTTTGTG 
M5452 cloning ILF3 Not-r gcgGCGGCCGCTTATCTGTACTGGTAGTTCATGCTG 
M5493 Site-Direct Mut PICH S774D f AGTTCCAAAATGGCAGATGTAGTCATTGATGAT 
M5494 Site-Direct Mut PICH S774D r ATCATCAATGACTACATCTGCCATTTTGGAACT 
M5495 Site-Direct Mut PICH S807D f GGTAAAGGTACAGGTGATGCTGACTCTATAGCT 
M5496 Site-Direct Mut PICH S807D r AGCTATAGAGTCAGCATCACCTGTACCTTTACC 
M5497 Site-Direct Mut PICH S810D f ACAGGTAGTGCTGACGATATAGCTACTTTACCA 
M5498 Site-Direct Mut PICH S810D r TGGTAAAGTAGCTATATCGTCAGCACTACCTGT 
M5499 Site-Direct Mut PICH S864D f GAGGATCCTCTGGAAGATTTTAATTATGTACTT 
M5500 Site-Direct Mut PICH S864D r AAGTACATAATTAAAATCTTCCAGAGGATCCTC 
M5528 cloning PICH TPR r1 CTCGAG TTAGATTCTGCTCAGCACTTTTTCATTG 
M5529 cloning PICH TPR f2 GGTACC C GCTACAAATGACTATGAGACTCTTG 
M5530 cloning PICH TPR f3 GGTACC C CAAAAAATACAGGAAGCCTTGGAG 
M5531 cloning PICH TPR r3 CTCGAG TTACTCTGCCGCCTTATCCTGGGGAGA 
M5536 Site-Direct Mut PICH F44A f GAAGCATTTAAACTTGCCAATTTGGCAAAGGAC 
M5537 Site-Direct Mut PICH F44A r GTCCTTTGCCAAATTGGCAAGTTTAAATGCTTC 
M5538 Site-Direct Mut PICH L1223A f falsche sequence bestellt 
M5539 Site-Direct Mut PICH L1223A r falsche sequence bestellt 
M5557 Site-Direct Mut PICH S995A f GCAGGGTTTGTGCATGCAAAAACATGTCTCAGT 
M5558 Site-Direct Mut PICH S995A r ACTGAGACATGTTTTTGCATGCACAAACCCTGC 
M5560 Site-Direct Mut PICH L1223A f2 falsche sequence bestellt 
M5561 Site-Direct Mut PICH L1223A r2 falsche sequence bestellt 
M5567 Site-Direct Mut PICH S1028A f GCTAGAAGGATTGTTGCAGATGGCGAAGATGAA 
M5568 Site-Direct Mut PICH S1028A r TTCATCTTCGCCATCTGCAACAATCCTTCTAGC 
M5569 Site-Direct Mut PICH S1028E f GCTAGAAGGATTGTTGAAGATGGCGAAGATGAA 
M5570 Site-Direct Mut PICH S1028E r TTCATCTTCGCCATCTTCAACAATCCTTCTAGC 
M5571 cloning PICH-Splice2 f gcgCTCGAG CG ATGGGATTAGGGAAGACTGTTCAAA 
M5658 Site-Direct Mut PICH L1223A f3 GAG GCC CTA AAC TGC  GCA   GTT AAA GCG CTT GAC 
M5659 Site-Direct Mut PICH L1223A r3 GTCAAGCGCT TTAACTGCGC AGTTTAGGGC CTC 
M5675 Site-Direct Mut PICH S820A f CCAAAGGGGTTTGGAGCTGTAGAAGAACTTTGT 
M5676 Site-Direct Mut PICH S820A r ACAAAGTTCTTCTACAGCTCCAAACCCCTTTGG 
M5677 Site-Direct Mut PICH S960A f CTTTTCTTGGAAGACGCAGCAGACAACAGACAA 
M5678 Site-Direct Mut PICH S960A r TTGTCTGTTGTCTGCTGCGTCTTCCAAGAAAAG 
M5679 Site-Direct Mut PICH S968A f AACAGACAAAACTTTGCCAGTCAGTCTTTAGAG 
M5680 Site-Direct Mut PICH S968A r CTCTAAAGACTGACTGGCAAAGTTTTGTCTGTT 
M5681 cloning NudC f1 kpn1 gcg GGTACC C ATGGGCGGAGAGCAGGAGGAGGAG 
M5682 cloning NudC r1 xho1 gcg CTCGAG CTAGTTGAATTTAGCCTTGGAAAAA 
M5683 cloning NudC f1 nest GGAGCGTAGAGAGCGCGGGACTAG 
M5684 cloning NudC r1 nest GTGGGAAAGAAAGTTGGGTGGTTGC 
M5707 Site-Direct Mut PICH KEN-1 f AGAGTTTACCGAATTGGACAA GCA GCG GCT GTTGT 
GGTTTATAGGCTAATC 
M5708 Site-Direct Mut PICH KEN-1 r GATTAGCCTATAAACCACAACAGCCGCTGCTTGTCC 
AATTCGGTAAACTCT 
M5709 Site-Direct Mut PICH KEN-2 f CAGTCTTTAGAGCATGTTGAG GCA GCA GCT AGCT 
TGTGTGGCTCTGCACCT 
M5710 Site-Direct Mut PICH KEN-2 r AGGTGCAGAGCCACACAAGCTAGCTGCTGCCTCAA 
CATGCTCTAAAGACTG 
M5691 cloning PICH TPR f4 for peGFP Xho gcg CTCGA GCT CAAAAAATACAGGAAGCCTTGGAG 
M5692 cloning PICH TPR r4 rev peGFP Kpn gcg GGTACC TTACTCTGCCGCCTTATCCTGGGGAGA 
M5693 Site-Direct Mut repair T375A f cctaggctgctgtctgcacgggcttgttgtttg 
M5694 Site-Direct Mut repair T375A r CAAACAACAAGCCCGTGCAGACAGCAGCCTAGG 
M5696 cloning PHB2 nest f GCGGGGTAGAGGCGGGCCGGCACC 
M5697 cloning PHB2 nest r CCTCAAAAACTGGAGAAGCAGATC 
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M5698 cloning PHB2 Kpn f gcg GGTACC T ATGGCCCAGAACTTGAAGGACTTGG 
M5699 cloning PHB2 Xho r gcg CTCGAG TCATTTCTTACCCTTGATGAGGCTG 
M5713 cloning CamK2D f Kpn1 gcgGGTACC T ATGGCTTCGACCACAACCTGCACC 
M5714 cloning CamK2D r Xho1 gcgCTCGAG TTACTTGATGGGTACTGTTGGTGAC 
M5715 cloning CamK2D f nest CGCGCGTCTGCTCGCTTCTGGTC 
M5716 cloning CamK2D r nest GAATAAGTAGAAGGAGCTGACC 
M5738 Site-Direct Mut CaMK2d D136A f GGCATAGTTCACAGGGCCCTGAAGCCTGAGAATTTG 
M5739 Site-Direct Mut CaMK2d D136A f CAAATTCTCAGGCTTCAGGGCCCTGTGAACTATGCC 
M5961 Site-Direct Mut PICH S1076A f CCAGGAAGGTTCTTTGCATCTCAAATACCCAGT 
M5962 Site-Direct Mut PICH S1076A r ACTGGGTATTTGAGATGCAAAGAACCTTCCTGG 
M5964 cloning Plk1- f1 -Plk1 for C-term mCherry gcgGTTTAAACATGAGTGCTGCAGTGACTGCAGGG 
M5965 cloning Plk1- r1 -Plk1 for C-term mCherry gcgAAGCTTGGAGGCCTTGAGACGGTTGCTGGC 
M5966 cloning PICH- f1 -PICH for C-term gfp gcg CTCGAG CT atggaggcatcccgaaggtttcc 
M5967 cloning PICH- r1 -PICH for C-term gfp gcg GGTACC ATTGTTATTAAGTTGCTTATACA 
M6015 Site-Direct Mut PICH T168A-f GAATTCATCAAGTGGGCTCCAGGAATGAGAGTC 
M6016 Site-Direct Mut PICH T258A-f CTCCTCCTCACAGGAGCCCCAATCCAGAATAAT 
M6017 Site-Direct Mut PICH S-399A-f CTAATGGAGACGCGCGCACCTTTGGCTGAGCTA 
M6018 Site-Direct Mut PICH S1069A-f CCCAAAAATGACATCGCTCCACCAGGAAGGTTC 
M6029 cloning Plk1- r2 -for C-term mCherry (kpn1) gcg GGTACC GGAGGCCTTGAGACGGTTGCTGGC 
M6051 cloning CFP-f1 Xho1 gcg CTCGAG TC ATGGTGAGCAAGGGCGAGGAGCTG 
M6052 cloning CFP-r1 Apa1 mit stop gcg GGGCCC TTACTTGTATAGCTCGTCCATGCC 
M6053 cloning PICH kpn1 gcg GGTACC t atggaggcatcccgaaggtttccg 
M6054 cloning PICH-oSTOP Xho1 reverse primer gcg CTCGAG ATTGTTATTAAGTTGCTTATACAAA 
M6055 cloning RFP-f1 Xho1 gcg CTCGAG TC ATGAGCTAGCTGATTANGGAGAAC 
M6056 cloning RFP-r1 Apa1 gcg GGGCCC TCACTTGTGCCCCAGTTTGCTAGGG 
M6057 cloning Plk1 Kpn1 gcg GGTACC t ATGAGTGCTGCAGTGACTGCAGGG 
M6058 cloning Plk1-oSTOP Xho1 reverse primer gcg CTCGAG GGAGGCCTTGAGACGGTTGCTGGC 
M6059 Site-Direct Mut PICH S14A GAAGCCGAGGCCTTGGCCCCAGAGCAGGCTGCTC 
M6060 Site-Direct Mut PICH S441A GAAATGAGGGGGAAGATGCCCCAGATGTGGACC 
M6061 Site-Direct Mut PICH S755A CCACAGCCTCAGCCTGCACCTCTTCTAAGTACTC 
M6062 Site-Direct Mut PICH S946A GGAACCTTCAGCATCTGCACCACAGTATGCATGTG 
M6063 Site-Direct Mut PICH S1188A GAACAGTTGGTTGGTGCTCCCCAGGATAAGGCGG 
M6064 cloning PICH-NLSr xho1 CTCGAG TCACACCTTGCGCTTCTTCTTCGGCGG 
ATTGTTATTAAGTTGCTTATACAAACTTAAAG 
M6065 cloning PICH-NLSr Kpn1 GGTACC TCACACCTTGCGCTTCTTCTTCGGCGG 
ATTGTTATTAAGTTGCTTATACAAACTTAAAG 
M6118 Site-Direct Mut S14rev GAGCAGCCTGCTCTGGGGCCAAGGCCTCGGCTTC 
M6119 Site-Direct Mut S441rev GGTCCACATCTGGGGCATCTTCCCCCTCATTTC 
M6120 Site-Direct Mut S755rev GAGTACTTAGAAGAGGTGCAGGCTGAGGCTGTGG 
M6121 Site-Direct Mut S946rev CACATGCATACTGTGGTGCAGATGCTGAAGGTTCC 
M6122 Site-Direct Mut S1069rev GAACCTTCCTGGTGGAGCGATGTCATTTTTGGG 
M6123 Site-Direct Mut S1188rev CCGCCTTATCCTGGGGAGCACCAACCAACTGTTC 
M6124 Site-Direct Mut T258rev ATTATTCTGGATTGGGGCTCCTGTGAGGAGGAG 
M6155 Site-Direct Mut oligo-3mut-f GTTTTTCTGCTTACCACTCAGGTGGGAGGAGTGGG 
ATTGACATTAACTGCAGCA 
M6156 Site-Direct Mut oligo-3mut-r TGCTGCAGTTAATGTCAATCCCACTCCTCCCACCTG 
AGTGGTAAGCAGAAAAAC 
M6229 cloning PP1A-human Kpn1-f gcg GGTACC ATGTCCGACAGCGAGAAGCTCAACC 
M6230 cloning PP1A-human Xho1-r gcg CTCGAG CTATTTCTTGGCTTTGGCGGAATTG 
M6231 cloning nest PP1A-f GGAGGCAGGAGCGGGCCAGG 
M6232 cloning nest PP1A-r GATTTCTGTACAATCAATCC 
M6236 Site-Direct Mut PP1A-T320A-f GGAGGCCGACCCATC GCC CCACCCCGCAATTCC 
M6237 Site-Direct Mut PP1A-T320A-r GGAATTGCGGGGTGGGGCGATGGGTCGGCCTCC 
M6256 cloning PPP1R1A-f Kpn1 gcg GGTACC ATGGAGCAAGACAACAGCCCCCGAAAG 
M6257 cloning PPP1R1A-r Xho1 gcg CTCGAG TCAGACCGAGTTGGCTCCCTTGGAATC 
M6258 cloning PPP1R2A-f Kpn1 gcg GGTACC ATGGCGGCCTCGACGGCCTCGCAC 
M6259 cloning PPP1R2A-r Xho1 gcg CTCGAG CTATGAACTTCGTAATTTGTTTTGC 
M6294 cloning PP1A-human Kpn1-f gcg GGTACC C ATGTCCGACAGCGAGAAGCTCAACC 
M6295 cloning PPP1R1A-f Kpn1 gcg GGTACC C ATGGAGCAAGACAACAGCCCCCGAAAG 
M6296 cloning PPP1R2A-f Kpn1 gcg GGTACC C ATGGCGGCCTCGACGGCCTCGCAC 
M6313 Site-Direct Mut B56delta S566A f GAGTTCCTAACTGCC gcc CAGGAGGCTCTCTGA 
M6314 Site-Direct Mut B56delta S566A r TCAGAGAGCCTCCTGGGCGGCAGTTAGGAACTC 
M6322 cloning B56delta-f Kpn1 gcg GGTACC C ATGCCCTATAAACTGAAAAAGGAG 
M6323 cloning B56delta-r Xba1 gcg TCTAGA TCAGAGAGCCTCCTGGCTGGCAGTTAG 
M6355 cloning PP2B-420-480-f (autoinhibitory peptide) Kpn1 gcg GGTACC C GTGCTGACGCTGAAAGGCTTGACC 
M6355 cloning PP2B-420-480-r (autoinhibitory peptide + STOP) Xho1 gcg CTCGAG TCAATTAATTCGGTCTAAGCCCTTG 
M6357 cloning Hec1 Kpn1-f gcg GGTACC C ATGAAGCGCAGTTCAGTTTCCAGCG 
M6358 cloning Hec1 Xho1-r gcg CTCGAG TCATTCTTCAGAAGACTTAATTAG 
M6364 Site-Direct Mut PICH RRQVF-AAQAA f CTGTAGAGGAAAAAATATAC GCA GCA CAG GCT 
GCC AAGGACTCATTAATAAGACAAAC 
M6365 Site-Direct Mut PICH RRQVF-AAQAA r GTTTGTCTTATTAATGAGTCCTTGGCAGCCTGTGC 
TGCGTATATTTTTTCCTCTACAG 
M6369 Site-Direct Mut PICH FLRRTK-ALRATA f CTTAATGGCAATCATAAAACCCTAT GCT CTC AGG 
 GCG ACT GCA  GAAGACGTACAGAAGAAAAAGTCAAG 
M6370 Site-Direct Mut PICH FLRRTK-ALRATA r CTTGACTTTTTCTTCTGTACGTCTTCTGCAGTCGCC 
CTGAGAGCATAGGGTTTTATGATTGCCATTAAG 
M6371 Site-Direct Mut PICH RVVIF-AVAIA f CGGTTTAACATTAACTGCAGCAACT GCA GTG GCC 
 ATT GCT GACCCTAGCTGGAATCCTGCAACTG 
M6372 Site-Direct Mut PICH RVVIF-AVAIA r CAGTTGCAGGATTCCAGCTAGGGTCAGCAATGGCC 
ACTGCAGTTGCTGCAGTTAATGTTAAACCG 
M6375 Site-Direct Mut I1-T35E-f CGGAGGCGCCGCCCC  GAG CCTGCCACCCTCGTGC 
M6376 Site-Direct Mut I1-T35E-r GCACGAGGGTGGCAGGCTCGGGGCGGCGCCTCCG 
M6377 Site-Direct Mut I1-T35D-f CGGAGGCGCCGCCCC  GAC CCTGCCACCCTCGTGC 
M6378 Site-Direct Mut I1-T35D-r GCACGAGGGTGGCAGGGTCGGGGCGGCGCCTCCG 
B1 Site-Direct Mut PP1gT311A-f GCCACGAGACCTGTAACCCCTCCAAGGGGTATG 
B2 Site-Direct Mut PP1gT311A-r CATACCCCTTGGAGGGGTTACAGGTCTCGTGGC 
B15 cloning PP1a-Xho1-f gcg CTCGAG CT ATGTCCGACAGCGAGAAGCTCAACC 
B16 cloning PP1a-Kpn-r gcg GGTACC CTATTTCTTGGCTTTGGCGGAATTGC 
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B17 cloning PP1b-Xho1-f gcg CTCGAG CT ATGGCGGACGGGGAGCTGAACGTGG 
B18 cloning PP1b-Kpn-r gcg GGTACC TCACCTTTTCTTCGGCGGATTAGC 
B19 cloning PP1g-Xho1-f gcg CTCGAG CT ATGGCGGATTTAGATAAACTCAAC 
B20 cloning PP1g-Kpn-r gcg GGTACC CTATTTCTTTGCTTGCTTTGTGATC 
B21 Site-Direct Mut PP1aH124A-f CTGCTCCGTGGGAAC GCC GAGTGTGCCAGCATC 
B22 Site-Direct Mut PP1aH124A-r GATGCTGGCACACTCGGCGTTCCCACGGAGCAG 
B23 Site-Direct Mut PP1bH124A-f CTCTTAAGAGGAAAC GCT  GAGTGTGCTAGCATC 
B24 Site-Direct Mut PP1bH124A-r GATGCTAGCACACTCAGCGTTTCCTCTTAAGAG 
B25 Site-Direct Mut PP1gH125A-f CTTCTCAGAGGGAAC GCT GAATGTGCCAGCATC 
B26 Site-Direct Mut PP1gH125A-r GATGCTGGCACATTCAGCGTTCCCTCTGAGAAG 
B27 cloning PP1b-Kpn-f gcg G GAT CC C ATGGCGGACGGGGAGCTGAACGTGG 
B28 cloning PP1b-Xho1-r gcg CTCGAG TCACCTTTTCTTCGGCGGATTAGCTG 
B29 Site-Direct Mut PP1b-T316A-f TCTGGACGTCCTGTC GCT  CCACCTCGAACAGCT 
B30 Site-Direct Mut PP1b-T316A-r AGCTGTTCGAGGTGGAGCGACAGGACGTCCAGA 
B41 cloning PP1a-pET28-f Nde1 gcg CATATG  ATGTCCGACAGCGAGAAGCTCAACC 
B42 cloning PP1a-pET28-r Xho1 no stop gcg  CTCGAG   TTTCTTGGCTTTGGCGGAATTGCGG 
B43 cloning PP1b-pET28-f Nde1 gcg CATATG  ATGGCGGACGGGGAGCTGAACGTGG 
B44 cloning PP1b-pET28-r Xho1 no stop gcg  CTCGAG CCTTTTCTTCGGCGGATTAGCTGTTC 
B45 cloning PP1g-pET28-f Nde1 gcg CATATG  ATGGCGGATTTAGATAAACTCAAC 
B46 cloning PP1g-pET28-r Xho1 no stop gcg  CTCGAG TTTCTTTGCTTGCTTTGTGATCATAC 
B74 sequencing SA2-1 451down GAATTCGATGAGGATAGTGGAG 
B75 sequencing SA2-1 900down GATAGCTGAAATTCGAGCTATTTG 
B76 sequencing SA2-1 1352down GAGGAAGACAAGGTCCAAATGCC 
B77 sequencing SA2-1 1791down GGAAATATATACCACTGGACG 
B78 sequencing SA2-1 2241down GATAACTGAAAGCAGCTCTAC 
B79 sequencing SA2-1 2763down CAGTCTGCAACAGCTTTTTAATG 
B80 sequencing SA2-1 3233down CTACAGGAAAACGGAAAGTGG 
B97 cloning PICH Kpn1 rev for peGFP-C1 gcg GGTACC  TCAATTGTTATTAAGTTGCTTATAC 
B178 cloning BEND3 for pcDNA3.1 f Kpn1 gcg G GTA CCC ATGAACTCAACTGAATTCACCGAAG 
B179 cloning BEND3 for pcDNA3.1 r Xba1 gcg TCT AGA TCACTTCTCCACTTTCTTTGCTTTC 
B182 cloning Bend3-nes-f CTGTAGCAGAGAAGTTCCTTG 
B183 cloning Bend3-nes-r GTATTGCTCAGTCCCAAGGG 
B189 sequencing Bend3-seq1 CACTGACAACGACCCCAACATC 
B190 sequencing Bend3-seq2 CCTCACTGAGTTCCTGGACG 
B191 sequencing Bend3-seq3 CTGTTCCCCGAGCTCTTCAC 
B192 sequencing Bend3-seq4 CGGTGCCTTCTCCCTACCTG 
 
7.3 List of siRNA duplexes 
Target gene Sequence Source 
Gl2 
Acc. No. X65324, 153 - 173 relative 
to the first nucleotide of the start 
codon 
(Elbashir et al., 2001) 
Wapl2 AAGGTTAAGTGTTCCTCTTAT (Kueng et al., 2006) 
Wapl1 AACGGACTACCCTTAGCACAA (Kueng et al., 2006) 
PICH (corresponds to PICH-3) AGUAGGUGGUGUCGGUUUA (Hübner et al., 2009) 
Sgo1 CAGUAGAACCUGCUCAGAA (McGuinness et al., 2005) 
Sgo2 TCGGAAGTGTAATTTCTTATT Yen T., 2007 
5'UTR PICH AACTGGAACCCAATCCGAGGG  
3'UTR PICH AACTTCTGCCCTGCAACGCCC  
SA2-3UTR-1 AACTGAAGAAAGTGTAGGATA  
SA2-3UTR-2 AATCTAAGTGGAAGAGGAAAT  
Smc2-1 TGCTATCACTGGCTTAAATTT Ono T, Cell, 2003 
Smc2-2 CATATTGGACTCCATCTGCTT Ono T, Cell, 2003 
Hbo1 AAGAAATGCGCCTTCTTCTGA Liu X, PNAS, 2008 
PHB2-1 GAAUCGUAUCUAUCUCACA K Fukui, CurrBiol, 2007 
PHB2-2 CUGAACCCCUCUUGGAUUAAG K Fukui, CurrBiol, 2008 
BEND3-1 AACCTCAAGAAAGCAAAGAAA  
BEND3-2 AACCGAAGATGTAGAAGAAGT  
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7.4 List of antibodies 
7.4.1 Immunofluorescence 
Goat anti-BLM (Santa Cruz B.) 
CREST (Immunovision) 
mouse anti-Cyclin B1 (in-house production) 
mouse anti-GFP (in-house production) 
mouse anti-Hec1 (GeneTex) 
mouse anti-Lamin A+B2 (in-house production) 
mouse anti-Mad1 (Sigma) 
rabbit anti-Mad2 (Bethyl) 
mouse anti-myc (9E10, in-house production) 
rat anti-PICH (Baumann et al., 2007) 
mouse anti-PICH (in-house production) 
mouse anti-Plk1 (in-house production) 
rabbit anti-Plk1 (Abcam) 
mouse anti-Sgo1 (Abnova) 
rabbit anti-Sgo2 (Bethyl) 
mouse anti-alpha-tubulin (Sigma) 
rabbit anit-Rif1 (gift from Dr. Weidong Wang) 
 
7.4.2 Western blotting 
mouse anti-Aurora B (AIM1, BD Transduction) 
rabbit anti-Cdc27 (BD Biosciecne) 
mouse anti-Blinkin (Kiyomitsu et al., 2007) 
rabbit anti-Borealin (Klein et al., 2006) 
mouse anti-Bub1 (in-house production) 
mouse anti-Bub3 (BD Transduction) 
mouse anti-BubR1 (in-house production) 
mouse anti-Cdc20 (Chemicon) 
mouse anti-Cdc27 (BD Transduction) 
mouse anti-Cyclin B1 (Upstate) 
mouse anti-Flag (Sigma) 
mouse anti-GFP (in-house production) 
mouse anti-Hec1 (GeneTex) 
rabbit anti-histone H3-phospho-serine 10 (Upstate) 
mouse anti-Mad1 (Sigma) 
rabbit anti-Mad2 (Bethyl) 
monoclonal anti-Mps1 (Stucke et al., 2002) 
mouse anti-myc (9E10, in-house production) 
rabbit anti-PICH (Baumann et al., 2007) 
mouse anti-PICH (in-house production) 
mouse anti-Plk1 (in-house production) 
goat anti-SA2 (Bethyl) 
mouse anti-Sgo1 (Abnova) 
rabbit anti-Sgo2 (Bethyl) 
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rabbit anti-SMC1 (Abcam) 
rabbit anti-SMC3 (Bethyl) 
rabbit anti-Survivin (Biozol) 
rabbit anti-Tao1 (Bethyl) 
monoclonal anti-alpha-tubulin (DM1A, Sigma) 
rabbit anti-Wapl (Abcam) 
rabbit-IgG (Invitrogen) 
mouse-IgG (Invitrogen) 
 
 
7.5 Abbreviations 
All units are abbreviated according to the International Unit System. 
aa: amino acid 
AB: antibody (pAB: polyclonal, mAB: monoclonal) 
APC/C: anaphase-promoting complex/cyclosome 
ATP: adenosine-triphosphate 
A.U.: arbitrary units 
BEN: BEN domain (after BANP, E5R and NAC1) 
BSA: bovine serum albumin 
Blinkin: Bub-linking kinetochore protein 
BLM: Bloom syndrome helicase 
Bub: budding inhinhibited by benzimidazole 
BTR/BTB: the BTR complex (composed of BLM, TOP3A, RMI1) 
CAK: Cdk activating kinase 
Cdc: cell division cycle 
Cdk: cyclin-dependent kinase 
CENP: centromeric protein 
CIP: calf intestine phosphatase 
CKI: Cyclin-dependen kinase inhibitor 
CREST: Calcinosis cutis, Raynaud-Syndrom, Esophageale Dysfunktion, Sklerodaktylie, Teleangiektasia 
CPC: chromosomal passenger complex 
C-terminus: carboxy-terminus 
DAPI: 4´,6-diamidino-2-phenylindole 
DIC: differential interference contrast microscopy 
DMSO: dimethyl sulfoxide 
DNA/dsDNA: deoxyribonucleic acid (double stranded DNA) 
DSB: double-strand break 
EMSA: electrophoretic mobility shift assay 
FA: Fanconi anemia 
FACS: fluorescent activated cell sorting 
FBS: fetal bovine serum 
GFP: green fluorescent protein 
GST: glutathione S-transferase 
hrs: hour(s) 
Hec1: highly expressed in cancer protein 1 
H2B: histone H2B 
HJ: Holiday Junction 
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ICL: intra/inter-strand crosslink 
IgG: immunoglobulin G 
INCENP: inner centromere protein 
INO80: inositol requiring 80 
IPTG: isopropyl-beta-D-thiogalactopyranoside 
kDa: kilodalton 
KT: kinetochore 
Mad: mitotic arrest deficient 
MAP: mitogen-activated protein 
MARKK: microtubule affinity-regulation kinase kinase 
MBP: maltose binding protein 
MCAK: mitotic centromere-associated kinesin 
MCC: mitotic checkpoint complex 
MCS: multiple cloning site 
min: minute(s) 
MMS: methyl methan sulfonate 
MMC: mitomycin-c 
Mps1: multipolar spindle-1 
mRNA: messenger ribonucleic acid 
MT: microtubule 
MTOC: microtubule organizing center 
NEBD: nuclear envelope breakdown 
NLS: nuclear localization signal 
N-terminus: amino-terminus 
PBD: polo-box binding domain 
PBS: phosphate-buffered saline 
PCR: polymerase chain reaction 
PFD: PICH family domain 
PICH: Plk1-interacting checkpoint helicase 
Plk: polo-like kinase 
Rif1: RAP1-interacting factor 
qRT-PCR: quantitative real-time polymerase chain reaction 
RNA/siRNA: ribonucleic acid (small interfering RNA) 
RNAi: RNA interference 
rpm: rounds per minute 
SAC: spindle assembly checkpoint 
SDS-PAGE: sodium dodecylsulfate polyacrylamid gelelectrophoresis 
SF: superfamily 
shRNA: short hairpin ribonucleic acid 
siRNA: small interference ribonucleic acid 
SNF: sucrose non-fermeting 
ssDNA: single stranded deoxyribonucleic acid 
SWI: mating-type switching 
TAL: ZK-Thiazolidinone 
Tao1: Thousand and one amino acid protein 1, also known as MARKK 
TOP3A: topoisomerase 3 alpha 
TPR: tetratrichopeptide repeats 
UFB: ultra-fine DNA-bridge 
UTR: untranslated region 
WT: wildtype 
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